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5ABBREVIATIONS
AcNPV Autographa californica nuclear polyhedrosis virus
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate
CaM-KII Ca2+- and calmodulin-dependent protein kinase II
CNQX 6-cyano-7-nitroquinoxaline-2,3-dione
CNS central nervous system
DNQX 6,7-dinitroquinoxaline-2,3-dione
GABA γ-aminobutyric acid
GluR glutamate receptor
5-HT 5-hydroxytryptamine (serotonin)
iGluR ionotropic glutamate receptor
IMAC immobilised metal ion affinity chromatography
KBP kainate binding protein
LBD ligand binding domain
LIVBP bacterial leucine/isoleucine/valine-binding protein
LAOBP bacterial lysine/arginine/ornithine-binding protein
LTP long-term potentiation
mGluR metabotropic glutamate receptor
Mw molecular weight
NMDA N-methyl-D-aspartate
QBP glutamine binding protein
PAGE polyacrylamide gel electrophoresis
PDZ PSD-95/Dlg/ZO-1
PBP periplasmic binding protein
PKA cAMP-dependent protein kinase
PKC protein kinase C
6ABSTRACT
The ionotropic glutamate receptors (iGluRs) are postsynaptic ion channels
involved in excitatory neurotransmission. The iGluRs can be classified according to
their specific agonists into N-methyl-D-aspartate (NMDA), α-amino-5-hydroxy-3-
methyl-4-isoxazole propionic acid (AMPA) and kainate receptors. Each of these classes
contains several homologous subunits that assemble in a subtype-specific manner
into oligomeric (tetra/pentameric) complexes.
The iGluRs are integral membrane proteins for which there is as yet no structure
available. However, some structural features of the subunits, including the primary
structure and its modifications, topology and domain organisation, have been solved.
Extensive biochemical and biophysical characterisation has been so far hampered by
the lack of sufficient amounts of homogeneous material.
In this study, the production and purification of an AMPA-type glutamate
receptor was investigated. Recombinant GluRD receptors were expressed in
Spodoptera frugiperda Sf21 insect cells and purified by affinity chromatography.
The purified receptor preparation contained over 2000 pmol of high-affinity (Kd 52
nM) binding sites/mg protein and exhibited a single 110 kDa band on silver-stained
SDS-PAGE. A yield of 50-100 µg of purified receptor was obtained from one litre of
Sf21 suspension culture.
In addition, the ligand binding sites of an AMPA receptor subunit GluRD and
a kainate receptor subunit GluR6 were studied. Two discontinuous segments, S1 and
S2, which show sequence similarity to bacterial amino acid binding proteins, were
expressed as soluble secreted fusion proteins. The S1S2 fragment was shown to
comprise the ligand-binding domain in glutamate receptors as it reproduced the ligand
binding characteristics of an intact receptor. A role for the N-terminal third of the S2
segment in AMPA-selectivity was identified by studying chimaeric GluRD/GluR6
S1S2 fragments.
Moreover, the entire extracellular domain (XS1S2) and an N-terminal ~400
residue segment (X) were expressed in High Five insect cells as soluble affinity-
tagged recombinant proteins in order to study their structure and properties. The N-
terminal X domain was shown not to contribute to ligand binding, but was suggested
to participate in the oligomerisation of the extracellular domain as a hydrodynamic
analysis of the domains showed dimerisation of the XS1S2 ectodomain but not of the
S1S2 domain.
71. INTRODUCTION
1.1.  SYNAPTIC TRANSMISSION
The nervous system consists of neurons (1011 in human brain) and glial cells.
Neurons are excitable cells; they generate and propagate electrical signals along their
processes forming networks that transmit and process information. Neurons
communicate with each other at specialised junctions called synapses, originally
realised by Ramon y Cajal in 1888 and demonstrated by electron microscopy in the
1950s.
Chemical synapses can form between two neurons or a neuron and an effector
cell (e.g. a muscle cell or a secretory cell). The synapse involves a presynaptic nerve
ending, synaptic cleft and postsynaptic nerve ending (Fig. 1). In the presynaptic nerve
terminus the neurotransmitter is stored in vesicles, which upon depolarisation of the
nerve ending fuse to the plasma membrane in a Ca2+-dependent manner and release
the transmitter into the synaptic cleft. The postsynaptic plasma membrane contains
the receptors for neurotransmitters, which are of two types: ligand-gated channels
and G-protein coupled receptors. In the former, binding of transmitter results in the
opening of the channel and a resultant transmembrane ion flux. Transmitter binding
to a G-protein coupled receptor initiates a signal transduction cascade. Most
neurotransmitters are taken up from the synaptic cleft by the axon terminals or glial
cells, but acetylcholine is degraded in the cleft by acetylcholine esterase.
Neurotransmitters are released locally from the synaptic terminal into the
synaptic cleft where they bind to and activate postsynaptic neurotransmitter receptors.
Neurotransmission can be excitatory or inhibitory depending on the response of the
postsynaptic cell. The major excitatory transmitter in the central nervous system (CNS)
is the amino acid L-glutamate. γ-Amino butyric acid (GABA) is the most prominent
inhibitory transmitter in the forebrain, while glycine is the major inhibitory transmitter
in the spinal cord and brainstem. Other neurotransmitters include acetylcholine,
catecholamines, serotonin (5-HT), dopamine, histamine and ATP.
Virtually all neurons in the CNS respond to glutamate by depolarisation.
Typically, responses at glutamatergic synapses exhibit two components (Fig. 2). One
subclass of glutamate receptors called non-NMDA type glutamate receptors (GluRs)
are responsible for the rapid onset and decay portion of the excitatory postsynaptic
current (epsc), while another subclass known as NMDA receptors mediate the
component with slow rise time and decay (Westbrook and Jahr, 1989). Glutamate
responses are terminated by deactivation of receptors (dissociation of ligand from the
binding site) or desensitisation (closing of channel in the continued presence of agonist,
detected only experimentally).
1.2.  GLUTAMATE RECEPTORS IN MAMMALIAN CNS
Glutamate receptors have been implicated in many functions. They are the
most important receptors in excitatory neurotransmission and subject to activity-
dependent changes termed as “synaptic plasticity”, a mechanism suggested to underlie
8Figure 1. Schematic structure and function of a glutamatergic synapse. Upon depolarisation of
the presynaptic nerve terminus, Ca2+ channels open and Ca2+ ions flow in. Fusion of glutamate
containing vesicles is Ca-dependent. Vesicles release glutamate into the synaptic cleft where
it binds to glutamate receptors. Binding of glutamate to iGluRs opens cation channels causing
depolarisation of the membrane. Ca-flux via NMDA channels leads to activation of Ca-
dependent enzymes and further signal transduction. From the synaptic cleft glutamate is taken
up by glia cells, and finally returned to presynaptic terminus, where it is stored in vesicles.
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9Figure 2. Monosynaptic excitatory postsynaptic current (epsc) recorded from cultured CA1
hippocampal neurons demonstrates the two receptor components of the glutamate-mediated
epsc. (Adapted from Westbrook and Jahr, 1989).
learning and memory (reviewed in Malenka and Nicoll, 1999). Glutamate receptors
have also a trophic role supporting the growth of new neurons (reviewed in Crair,
1999). Furthermore, glutamate receptors have been implicated in pathological
conditions (reviewed in Choi, 1988).
1.2.1. Classification of glutamate receptors
Glutamate receptors fall into two major structural categories; ionotropic
glutamate receptors (iGluRs) have an integral ion channel, whereas metabotropic
glutamate receptors (mGluRs) are associated with G-proteins. The endogenous
neurotransmitter L-glutamate activates all glutamate receptors, but the development
of synthetic ligands as pharmacological tools has facilitated a further classification of
glutamate receptors (Fig. 3). Thus, iGluRs can be further classified as N-methyl-D-
aspartic acid (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) and kainate receptors according to their agonist affinities.
The AMPA receptors mediate the majority of all fast excitatory
neurotransmission. These receptors act with fast kinetics; the onset, offset and
desensitisation occur on a millisecond time scale (Jonas and Sakmann, 1992). The
endogenous agonist L-glutamate evokes currents carried mainly by the monovalent
ions Na+ and K+ and to a lesser extent by Ca2+ (Ascher and Nowak, 1988a). Their
specific agonist, AMPA, binds with high affinity (with a Kd in the low nanomolar
range) and evokes currents exhibiting an initial fast desensitising component followed
by a steady-state plateau similar to L-glutamate, whereas kainate activates non-
desensitising currents (Sommer et al., 1990). Native AMPA receptors exhibit two
types of channels, one showing low Ca2+ permeability and one with high Ca2+
permeability (Iino et al., 1990). Most native AMPA receptors exhibit low Ca2+
Figure 3. Structures of some glutamate receptor agonists. (Adapted from Armstrong et al.,
1998).
permeability and linear current-voltage (I/V) relations (Mayer and Westbrook, 1987;
Acher and Nowak, 1988b; Jonas and Sakmann, 1992). Minor subpopulations of
neurons such as GABAergic interneurons express Ca2+ -permeable AMPA receptors
with doubly rectifying I/V relations (reviewed in Jonas and Burnashev, 1995). The
rectification is caused by cytoplasmic factors; endogenous polyamines (spermine,
spermidine) block AMPA and kainate channels at resting membrane potentials in an
activity-dependent manner (Bowie and Mayer, 1995; Bowie et al., 1998).
Kainate receptors have similar fast activation and inactivation kinetics and a
similar affinity for glutamate as do the AMPA receptors (review by Lerma,  1997).
The agonists L-glutamate, kainate, quisqualate and domoate elicit currents with inward
rectifying I/V relations and low Ca2+ permeability (Lerma et al., 1993). Kainate and
AMPA receptors are often referred to as non-NMDA receptors, as they are
pharmacologically not easily distinguished from one another.
In addition to glutamate, another endogenous agonist for NNIDA, receptors is
aspartate, unlike in the case of non-NMDA receptors. The NMDA responses exhibit
slower kinetics than the non-NMDA receptors, the current peaks approximately 10 ms
after  the non-NMDA receptor peak current and the depolarisation lasts  for hundreds
of  milliseconds (Lester et  al., 1990).  NNIDA. receptors  display two unique features:
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they require glycine as a coagonist (Johnson and Ascher, 1987; Kleckner and
Dingledine, 1988) and are blocked by Mg2+ ions in a voltage-dependent manner (Nowak
et al., 1984; Mayer et al., 1984). Mg2+ ions block the current at normal negative
membrane potentials whilst at positive potentials they have almost no effect.
Depolarisation of the membrane releases the block and conductance of the channel
increases. Like AMPA receptors, NMDA receptors show desensitisation in the
continued presence of the agonist. However, they exhibit three kinds of desensitisation
mechanisms depending upon the glycine and Ca2+ concentrations (Mayer et al., 1989;
Sather et al., 1990). NMDA receptors are also regulated by a number of extracellular
agents such as polyamines, Zn2+ and H+. Polyamines potentiate NMDA-mediated
currents by increasing the NMDA receptors mean open time (Lerma, 1992; Durand et
al., 1992; Masuko et al., 1999). Zn2+, which is an abundant cation in excitatory terminals
and is released into the synaptic cleft during neurotransmission (Assaf and Chung,
1984), inhibits currents mediated by NMDA receptors by binding to a site distinct
from the Mg2+ binding site (Westbrook and Mayer, 1987). NMDA receptors are further
regulated by the extracellular H+ concentration. They are inhibited almost completely
at pH5, and at physiological pH about half of the NMDARs are still inhibited (Tang et
al., 1990; Traynelis and Cull-Candy, 1990).
The metabotropic glutamate receptors have no integral channel and they
mediate slow, modulatory actions of glutamate in the nervous system by coupling,
via GTP-binding proteins, either to inositol-1,4,5-trisphosphate (IP3) formation and
intracellular Ca2+ mobilisation or to cAMP formation. There are three groups of mGluRs
based on their pharmacological properties and coupling to second messenger systems.
Group I mGluRs activate type G
o
/Gq family G proteins, which then stimulate
phospholipase C leading to hydrolysis of membrane phosphoinositides. Groups II
and III activate inhibitory Gi type G proteins, which inhibit adenylyl cyclase. The
mGluRs reside generally in the periphery of synaptic junctions, but some subtypes
may modulate glutamate release at presynaptic sites (Baude et al., 1993; reviewed in
Nakanishi, 1994).
1.2.2. Glutamate receptors and synaptic plasticity
Activity-dependent modulation of neuronal connectivity is termed “synaptic
plasticity”. Synaptic plasticity is involved in memory acquisition, learning and
development of the nervous system. It has been well-studied in hippocampal slices,
where a laminar structure is maintained during slicing and cell layers are easily
distinquished. In an experimental model of long-term changes of synaptic strength,
tetanic stimulation of input pathways in pyramidal neurons induces two temporally-
distinct forms of synaptic potentiation: short-term potentiation (STP) that decays within
seconds to minutes and long-term potentiation (LTP) that can persist for days. LTP
has been suggested to be the synaptic basis of memory formation (reviewed in Bliss
and Collingridge, 1993).
LTP can be specifically blocked by NMDA receptor antagonists applied during
tetanic stimulation, thus indicating that NMDA receptors are critical in LTP induction.
The previously discussed molecular properties of NMDA receptors, in particular the
voltage-dependent Mg2+ blockage and Ca2+ permeability, are suitable for its role as a
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“coincidence detector” in associative LTP, where association of synaptic inputs is
needed to depolarise the postsynaptic membrane sufficiently with simultaneous
presynaptic glutamate release.
There are two views on the location of the site of LTP expression; both
presynaptic and postsynaptic mechanisms have been suggested. Regarding the
presynaptic mechanism, an increased probability of neurotransmitter release has been
reported (Malinov and Tsien, 1990; Bekkers and Stevens, 1990). An increase in
presynaptic activity in response to postsynaptic induction of LTP would require the
release of a diffusable messenger from the postsynaptic cell back into the synaptic
cleft. Arachidonic acid and nitric oxide have been suggested as candidate retrograde
signals (Bliss and Collingridge, 1993).
The postsynaptic mechanism of LTP would consist of an increased AMPA
receptor mediated response for which there are three possible mechanisms (Fig 4).
First, the growth of new spines making new synapses in response to neuronal stimulation
has been suggested (Maletic-Savatic et al., 1999). Second, increasing amounts of AMPA
receptors in the postsynaptic membrane by delivery and clustering of receptors into
spines from internal pools (Shi et al., 1999). A special form of this second possibility
occurs during neuronal development when so-called “silent synapses” are activated
(Durand et al., 1996). Silent synapses contain NMDA receptors, but lack AMPA
receptors and thus fail to respond to glutamate (Isaac et al., 1995; Liao et al., 1995).
Insertion of AMPA receptors into the silent synapses enhances synaptic function (Shi
et al., 1999). A third mechanism that can increase the postsynaptic response involves
modulating the activity of existing synaptic receptors by covalent modifications such as
phosphorylation, thereby allowing more ions to pass (Barria et al., 1997). It is probable
that all three mechanisms are used by neurons.
The molecular mechanisms leading to the aforementioned increase in synaptic
strength have been studied intensively. A crucial event seems to be the NMDA receptor
mediated rise in the postsynaptic calcium concentration, which triggers a cascade of
biochemical events (reviewed in Ghosh and Greenberg, 1995). Ca2+ binds to Ca2+-
dependent enzymes, e.g. Ca2+-calmodulin dependent kinase (CaM-KII) thereby
activating them. This leads to activation of signalling pathways propagating the signal
through to the nucleus where it activates transcription factors leading to synthesis of
new proteins, which has been shown to be needed in order to convert STP into LTP
(Casadio et al., 1999).
Long-term depression (LTD) is an opposite event to LTP characterised by
use dependent decrease in synaptic strength: weakening of synapses is induced by
low-frequency stimulation. Pathways involved in induction of LTD are complex and
involve many of the same components as with LTP. NMDA receptor-mediated Ca2+-
entry to postsynaptic cell is one mechanism, inducing intracellular events (e.g.
dephosphorylation of sinalling proteins) leading to LTD. Contrary to LTP, expression
of LTD seems to involve removal of AMPA receptors from synapses (Luthi et al.,
1999).
During development, glutamate receptors are involved in neuronal
differentiation, migration and activity-dependent synapse formation. NMDA receptors
have been suggested to regulate activity-dependent neural circuit development. One
13
Figure 4. Simplified model for the expression of LTP. Ca2+ ions flowing into the dendritic
spine through NMDA receptors bind to calmodulin (CaM) to activate CaM kinase II by
autophosphorylation. CaMKII phosphorylates AMPA receptors already present in the
postsynaptic membrane, thus increasing their channel conductance. It has also been suggested
that CaMKII activity is involved in the insertion of more AMPA receptors into the postsynaptic
membrane. (After Malenka and Nicoll, 1999).
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14
mechanism might be through expression of different NMDA receptors subunits, which
are expressed differently during development and have distinct ionic conductances
(reviewed in Crair, 1999).
1.2.3. Pathophysiology of glutamate receptors
All excitatory neurotransmitters are toxic to neurons in high concentrations
and/or when exposed for long periods, a condition termed excitotoxicity (reviewed in
Choi, 1988; Lee et al., 1999; McNamara, 1999). Glutamate excitotoxicity has been
shown in animal models and cell culture, where AMPA and NMDA receptor
antagonists provide protection from cell death and neuronal damage. This pathological
condition can occur in stroke, hypoxia and hypoglycemia via energy depletion resulting
in the decreased uptake of synaptically released glutamate by glutamate transporters
and accumulation of extracellular glutamate. The immediate effect in ischemic (resulting
from deprivation of blood supply) trauma is the overactivation of iGluRs and Na+ and
Cl- flux into neurons, resulting in osmotic swelling and necrosis of cells. Secondarily,
influx of calcium may trigger apoptotic pathways leading to further loss of neurons.
In addition to these acute insults, glutamate neurotoxicity can be a factor in
several chronic neurological diseases. For example, epileptic seizures result from a
persistent increase in neuronal excitability (reviewed in McNamara, 1999). Glutamate
receptors have been suggested also to have a role in degenerative diseases such as
Alzheimer’s disease or Huntington’s disease, which feature gradual, selective loss of
neurons (reviewed in Choi, 1988).
1.3. MOLECULAR ANALYSIS OF IONOTROPIC GLUTAMATE RECEPTORS
Initially, the presence of glutamate binding sites in the brain was shown by
direct radioligand binding to membranes and ligand autoradiography of brain slices.
NMDA and AMPA/kainate –binding sites have been solubilised and purified from
rat, pig and bovine brain (e.g. Henley and Barnard, 1989; Chang et al., 1991; Wenthold
et al., 1992; Hall et al., 1992). The iGluRs in mammalian brain are of low abundance
and thus the material obtained in these experiments has been heterogeneous. However,
these experiments have shown that the glutamate receptor is an oligomeric complex,
which can be extracted in detergent solutions in an active form.  In contrast to
mammalian brain, high-affinity kainate binding sites are abundant in lower vertebrates.
A kainate-binding protein (KBP), which shows pharmacological similarities to
mammalian kainate receptors, has been purified to 90 % homogeneity from chick
cerebellum by conventional fractionation (Gregor et al., 1988). Since 1989, cDNAs
encoding subunits of iGluRs have become available, making it possible to express
these proteins in heterologous systems and to obtain more detailed information on
their molecular characteristics.
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1.3.1. Subunit structure
1.3.1.1. Molecular cloning of the iGluR subunits
Ionotropic glutamate receptors are oligomeric proteins, which presumably
consist of four or five homologous subunits. To date, 17 different subunits have been
identified by molecular cloning, which correspond to the known pharmacological
subclasses of the glutamate receptors.
AMPA receptors
The use of oocyte expression systems and functional cloning resulted in the
isolation of the first glutamate receptor cDNA clone (Hollmann et al., 1989). Injection
of in vitro transcripts from pools of rat brain cDNA-library into Xenopus oocytes and
subsequent analysis of kainate responses in the injected oocytes allowed subpooling
of the library until a single clone was obtained. This clone was named GluR-K1, as it
was originally regarded as a kainate receptor. At the same time cDNAs encoding two
kainate-binding proteins from frog and chick were isolated and characterised (Wada
et al., 1989; Gregor et al., 1989). Subsequently, homology screening was used to
isolate several further cDNA clones (Keinänen et al. 1990; Boulter et al., 1990;
Nakanishi et al., 1990). The cloned subunits, termed alternatively as GluRA-D or
GluR1-4, represented AMPA receptor subunits as confirmed by typical AMPA
responses and [3H]AMPA binding in cells expressing the cDNAs. AMPA receptor
subunits are able to form homomeric receptors, but native receptors are believed to be
mainly heteromeric assemblies. In situ hybridisation revealed that the AMPA receptor
subunits are abundantly expressed in the brain in different layers of the cerebral cortex,
caudate-putamen, hippocampus, cerebellum (in different cell layers) and olfactory
bulb. GluRA and -B are also expressed in the hypothalamic nuclei and in amygdala
(Keinänen et al., 1990).
The different AMPA receptor subunits have very similar pharmacologies,
thus  the targeted disruption of specific subunit genes has been employed to study the
specific functions of one AMPA receptor subunit, GluRB. A GluRB subunit knock-
out results in impairment in the behaviour of GluRB-/- mice, indicating that the GluRB
subunit is critical for normal brain function (Jia et al., 1996).
Kainate receptors
Cloning of the five members of the kainate receptor family was carried out
soon after the cloning of the AMPA receptor subunit. The kainate receptor subunits
can be grouped in two classes based on their affinities to kainate: the lower affinity
(Kd 50-100 nM) kainate binding subunits GluR5-7 (Bettler et al., 1990; Egebjerg et
al., 1991; Bettler et al., 1992) and the high-affinity (Kd ~5 nM) kainate receptor subunits
KA-1 and KA-2 (Werner et al., 1991; Herb et al., 1992). GluR5-7 subunits are able to
make homomeric channels that respond to glutamate and kainate with rapidly
desensitising currents (Bettler et al 1992). In contrast, the KA1 and KA2 subunits are
functional only when coexpressed with GluR5, GluR6 or GluR7, suggesting that they
exist only as heteromeric complexes in the CNS (Herb et al., 1992). Heteromers
containing KA1 or KA2 generate fast and fully desensitising currents but, in addition
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to glutamate and kainate, they also respond to AMPA (Herb et al., 1992; Schiffer et
al., 1997). GluR7 has a ten-fold lower affinity to glutamate than other AMPA and
kainate receptors and, unlike other kainate receptor subunits, is insensitive to domoate.
GluR5 is mainly expressed during development, but lower levels are expressed
also in several regions of adult rat brain, including cingulate and piriform cortex, several
hypothalamic nuclei, amygdala and lateral septum (Bettler et al., 1990). GluR6 transcripts
are found at high levels in adult rat brain in the cerebellar and dentate granule cell
layers, pyriform cortex, caudate-putamen and the hippocampal CA3 region (Egebjerg
et al., 1991). The GluR7 expression pattern overlaps with GluR6 expression; it is
expressed in inner cortical layers, hippocampal CA3 and dentate gyrus regions, reticular
thalamic nucleus, mammillary bodies, pons and cerebellum (Bettler et al., 1992). The
distribution of KA-1 and KA-2 overlaps with expression patterns of GluR6 and GluR7.
KA-1 is restricted to hippocampal regions CA3 and dentate gyrus, whereas KA-2 is
more widely expressed in adult rat brain in all hippocampal regions, cerebellum, cerebral
cortex, pyriform cortex and caudate-putamen (Herb et al., 1992).
Disrupting the GluR6 gene does not cause obvious physiological effects.
Kainate receptor deficient GluR6-/- mice are healthy, and are less sensitive to the
neurotoxin kainate, thus exhibiting reduced susceptibility to kainate-induced seizures
(Mulle et al., 1998).
NMDA receptors
The first NMDA receptor subunit, NR1, was isolated by expression cloning
using Xenopus oocytes (Moriyoshi et al., 1991), whilst NR2A-D (Monyer et al., 1992;
Ishii et al., 1993) and NR3 subunit cDNAs (Ciabarra et al., 1995; Sucher et al., 1995)
were isolated by homology screening. The NMDA receptor subunit NR1 is regarded
as an obligatory subunit of the NMDA receptor, in contrast, NR2A-D are considered
as more modulatory subunits. NR1 is expressed in all parts of the brain and during all
developmental stages (Moriyoshi et al., 1991). NR2A is expressed after birth in the
entire brain, but it is most prominent in the cerebral cortex, hippocampus, cerebellum
and olfactory bulb. NR2B is widely expressed at embryonic stages, but becomes
more restricted in localisation after birth, with its main expression in the forebrain.
NR2C is expressed postnatally in cerebellum, whilst NR2D is expressed at embryonic
stages in the diencephalon and lower brainstem regions; its mRNA levels are strongly
reduced after birth (Ishii et al., 1993).
The roles of NMDA receptors were confirmed by studies on genetically
modified mice. NR1-/- mice die perinatally due to respiratory failure, but show no
obvious structural or histological defects in the CNS (Li et al., 1994; Forrest et al.,
1994). NR2B-/- mice also die soon after birth presumably because they are not able to
feed (Kutsuwada et al., 1996). NR2A-/-, NR2C-/- and NR2D-/- mice are viable and show
normal brain morphology, but exhibit deficiencies in motor functions (Sakimura et
al., 1995; Ikeda et al., 1995; Ebralidze et al., 1996; Kadotani et al., 1996). Thus, it
seems that the NR1/NR2B subtype is vitally important, whereas other NR2 subunits
may serve less crucial roles or are more easily compensated by other subunits.
The NR3 subunit is expressed in the adult rat brain in thalamus and spinal
cord, but much higher levels of the mRNA transcript are detected in the developing
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brain (Ciabarra et al., 1995). NR3 shows rather low sequence similarity (around 27%
identity) to other NMDA receptors and may function as a modulatory subunit; no
independent function has been assigned to it. NR3 subunit expression peaks at the
second postnatal week and very little is expressed in the adult rodent brain. Therefore,
NR3 has been suggested to have a role in neurite outgrowth and synapse formation
(Sucher et al., 1995). This is supported by the observation that in NR3-/- mice the
morphology of dendritic spines is modified (spine heads were enlarged and necks
elongated) and their number is increased (Das et al., 1998).
Two further subunits having 27% sequence identity to other iGluRs were
identified by homology screening of cDNA libraries and termed δ1 and δ2 (Lomeli et
al., 1993). They do not respond to glutamate or any other ligands and accordingly
they are called “orphan” receptors. The δ2 subunit is selectively localised in the
cerebellum and disruption of the δ2 gene in mouse produces a phenotype with impaired
motor coordination and reduced cerebellar long-term depression (LTD), which has
been suggested to be the cellular basis for motor learning (Kashiwabuchi et al., 1995).
The iGluR subunits in mammals are extremely well conserved between species
showing >95% amino acid identity between homologous subunits in rat, mouse and
human (Puckett et al., 1991; Planelles-Cases et al., 1993). GluRs are also found in
other vertebrates, e.g. fish (85% sequence identity between homologous subunits,
Kung et al., 1996) and in invertebrates, but here the similarity is lower, e.g.  less than
50% amino acid identity between mollusc or insect and mammalian iGluRs (reviewed
in Darlinson, 1992). Furthermore, Caenorhabditis elegans has glutamate receptors in
the inter- and motor neurons, which show closest sequence similarity to the AMPA
receptors (Maricq et al., 1995). Surprisingly, a family of iGluR subunits has been
identified in the plant Arabidopsis thaliana. Preliminary results suggest that two of
these proteins (GLR1 and GLR2) may be involved in light signalling (Lam et al.,
1998). The two clones show sequence identity of less than 20% overall, but in certain
domains up to 60% with the mammalian glutamate receptors. Quite recently, a
prokaryotic glutamate receptor, GluR0, was described from Synechocystis. GluR0
shows amino acid sequence homology to both eukaryotic glutamate receptors and
potassium channels, and has thus been suggested to form a link between these two ion
channels (Chen et al., 1999).
1.3.1.2. Primary structure
The sequences of the ionotropic glutamate receptors code for polypeptides of
around 900 amino acids with apparent molecular mass of ~100 kDa, except for the
NMDAR2 subunits, which have a large (350-600 aa) carboxy-terminal extension,
and thus exhibit polypeptide lengths of 1250-1482 amino acids. The KBPs differ
from the other glutamate receptors in lacking the large N-terminal domain thus having
less than 500 aa with M
r 
~49 kDa. The sequence identities within subfamilies are 50-
70% and between subfamilies 20-40%. Hydrophobicity analysis predicted that the
ionotropic glutamate receptor polypeptides have an N-terminal signal sequence and
four putative transmembrane segments (M1-M4), three closely spaced in the middle
of the polypeptide and the fourth closer to the C-terminus. Several concensus
glycosylation and phosphorylation sites are present in the subunit polypeptides.
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Figure 5. Schematic presentation of the AMPA receptor subunit structure. The N-terminus of
the receptor is on the extracellular side as well as the ligand-binding domain forming S1 and
S2 segments. The C-terminus is intracellular. The subunit has three membrane traversing
segments and one re-entrant loop (M2).
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1.3.1.3. Topology
The topology of a membrane protein defines the orientation of the protein
with respect to the plane of the membrane indicating which parts of the protein are
extracellular and which are intracellular. Glutamate receptors have an N-terminal
signal sequence suggesting that the entire amino-terminal part until the first
transmembrane segment is extracellular. This has been confirmed by a mutagenesis
study showing that amino acids preceding M1 are involved in the binding of ligand
and therefore must reside extracellularly (Uchino et al., 1992).
Hydropathy analysis of glutamate receptor sequences predicted an even
number (four) of transmembrane domains. The simplest model deduced from this
prediction would place the carboxy-terminal part of the receptor subunit on the
extracellular side together with the amino-terminus. This is, however, not consistent
with the experimental evidence. Ionotropic glutamate receptors are regulated by
phosphorylation (Keller et al., 1992; McGlade-McCulloh et al., 1993). Several C-
terminally located serine residues in NR1 were found to be phosphorylated and since
phosphorylation by PKA and PKC is an intracellular event, the C-terminus must be
intracellular (Tingley et al., 1993).
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As the N- and the C-termini reside on different sides of the membrane, there
must be an uneven number of transmembrane segments. The orientation of the large
hydrophilic loop between M3 and M4 has been studied by glycosylation and
phosphorylation site mapping. Initially, this loop was reported to be phosphorylated
at Ser684 (GluR6) and Ser696 (GluRB; Raymond et al., 1993; Wang et al., 1993;
Nakazawa et al., 1995) implying that the loop is intracellular. On the other hand, Asn720
in GluR6 is N-glycosylated and should therefore be extracellular (Roche et al. 1994;
Taverna et al., 1994). The membrane topology of the homologous goldfish kainate
binding protein has been studied by deleting the M2 segment. If this was a true
transmembrane segment, then in the deletion mutant the rest of the polypeptide would
have an inverted topology. The goldfish KBP has a single N-glycosylation site in the
M3-M4 loop, which is glycosylated irrespective of the presence of M2, indicating that
M2 is not a true transmembrane domain (Wo and Oswald, 1994; Wo and Oswald,
1995a). Furthermore, new potential N-glycosylation sites were introduced into the
GluR1 AMPA receptor subunit and their susceptibility to glycosylation was studied
(Hollmann et al., 1994). This study showed that the loop between M3 and M4 resides
extracellularly. Thus, apart from the contradictory phosphorylation studies most of
the experimental evidence favors a model in which the termini are on opposite sides
of the membrane and M2 does not traverse the membrane, but rather forms a re-
entrant loop (Fig. 5).
1.3.1.4. Modular structure of the iGluRs
Structure-function studies for glutamate receptors became relevant after the
subunit sequences were obtained. Important problems to be addressed included the
location of the agonist binding site, the ion channel and the structures which couple
binding to channel gating, as well as the location of allosteric regulatory elements.
Sequence comparisons revealed two separate homologies to bacterial proteins which
bind amino acids (Nakanishi et al., 1990; O’Hara et al., 1993). The first is located in
the amino-terminal domain and the second is over the segments preceding M1 and
between M3 and M4. This suggests a modular structure for glutamate receptors (Fig.5;
reviewed in Wo and Oswald, 1995b), in which different parts may interact in an
allosteric fashion. This modular character is also supported in the interchangeability
of parts in chimaeric receptors (e.g. Stern-Bach et al., 1994; Villmann et al., 1997;
Villmann et al., 1999).
The pore
To study the channel structure, the segments forming the channel needed to
be located; from the primary structure the likely location is in the hydrophobic segments
M1-M4. Several pieces of evidence suggest that the M2 segment has a critical role in
channel formation. The sequence of the M2 segment is more hydrophilic than the
other predicted transmembrane segments. It has also been shown to share sequence
homology to a K+ channel pore-loop domain, for which the structure has been determined
and shown to be a re-entrant loop (Bennet and Dingledine, 1995; Wood et al., 1995).
The most convincing evidence for the role of M2 in forming the channel comes from
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studies in which a single amino acid was found to be critical for ion permeability. This
residue is in the so-called Q/R site, which resides in M2 and is occupied by an arginine
residue in GluRB subunits, whereas in other AMPA receptors a glutamine residue is
found in this position (Verdoorn et al., 1991; Hume et al., 1991; Burnashev et al., 1992).
The identity of the amino acid at this site determines the Ca2+-permeability and
rectification observed in the current-voltage relation of AMPA mediated currents. An
arginine residue makes the channel Ca2+ impermeant with linear or inwardly rectifying
I/V relations, whereas a glutamine residue is responsible for Ca2+ permeant channels
with doubly rectifying I/V relationships. In the NMDA receptors an asparagine located
at this site (therefore termed as the Q/R/N site) imparts to the receptor the voltage-
dependent blockage by Mg2+ (Burnashev et al., 1992). Taken together, these results
suggest that the M2 segment constitutes a critical part of the channel domain.
The M1 and M3 segments also contribute to the channel. The NMDA receptor
open channel blockers phencyclidine (PCP) and dizocilpine (MK-801) bind to residues
in the M2 and M3 segments. Mutational analysis identified PCP and MK-801 binding
sites, which involved residues in NR1: Asn-598 and Trp-593 in M2 and Ala-627 in
M3 (Ferrer-Montiel et al., 1995). In the GluR6 kainate receptor, the M1 segment also
has two sites critical for Ca2+-permeability, the so-called I/V and Y/C sites, which are,
like the Q/R site in AMPA receptors, subject to RNA editing (Köhler et al., 1993; see
chapter 1.3.2.1.). Hence, it seems likely that the transmembrane segments M1 and
M3 contribute to the channel.
The structure of the M2 domain, previously thought to span the membrane,
was studied by using engineered epitopes sensitive to proteolysis, together with native
and introduced glycosylation sites. The structure of the pore was assessed by using the
substituted cysteine accessibility method (SCAM, Kuner et al., 1996). The periodicity
of the exposed residues is compatible with an α-helical secondary structure for the
main part of M2 and an extended structure for its C-terminal part.
The channel is likely to consist structurally of two vestibules separated by a
narrow constriction. The diameter of the pore has been estimated by measuring the
permeation of different ions through the NMDA receptor channel, and a value of 5.5
Å has been reported (Villarroel et al., 1995). In the same study, the diameter of the
outer and inner vestibules was determined to be around 7.3 Å. For homomeric AMPA
and kainate receptors the channel constriction seems bigger, 7.6-7.8 Å in diameter
(Burnashev, 1996); the Q/R site does not affect the pore size.
The outer vestibule of the NMDA receptors contains a binding site for the
divalent ions Ca2+ and Mg2+ (Premkumar and Auerbach, 1996). The endogenous
polyamines (PA) spermine and spermidine bind to two sites, one near the cytoplasmic
side of the pore and the other in the outer vestibule (Bowie and Mayer, 1995; Washburn
and Dingledine, 1996; Bowie et al., 1998).
The glutamate receptor channel structure is thus not yet known, but the
structures of two other membrane channels are available. The three dimensional
structure of a bacterial tetrameric K+ channel homologous to mammalian channels
has been determined by X-ray crystallography. The channel is formed by a selectivity
filter surrounded by a cone of α-helices. The selectivity filter is a similar hairpin loop as
in the glutamate receptors, but with an inverted orientation in the membrane (Doyle et
21
al., 1998). An entirely different channel structure is present in the nicotinic acetylcholine
receptor, consisting of five membrane traversing α-helices (Hucho et al., 1986; Imoto
et al., 1986; Toyoshima and Unwin, 1988; Unwin, 1995).
Extracellular domains
Two separate ~150 residue segments, termed S1 and S2 (Fig. 5) show
homology to the glutamine binding protein QBP and the lysine/arginine/ornithine–
binding protein LAOBP (Nakanishi et al., 1990; O’Hara et al., 1993; Stern-Bach et
al., 1994). The amino-terminal ~400 residue segment preceding S1 shows a more
distant similarity to the bacterial periplasmic leucine/isoleucine/valine–binding protein
(LIVBP), leucine binding protein (LBP) and to the N-terminal segment of mGluRs
(O’Hara et al., 1993).
The ligand-binding domain (LBD) of glutamate receptors has been shown to
consist of the S1 and S2 segments. With mutations based on sequence similarity to
LAOBP and QBP, it was possible to identify amino acids in the NR1 subunit of the
NMDA receptor that are important for activation by the co-agonist glycine (Kuryatov
et al., 1994).  Chimaeric proteins made between GluRC and GluR6, and GluRB and
GluR6 were originally used to identify the crucial role of the S1 and S2 segments in
agonist binding for AMPA and kainate receptors (Stern-Bach et al., 1994; Tygesen et
al., 1995). After the studies by Stern-Bach et al. (1994) and Kuryatov et al. (1994), it
was directly demonstrated that S1 and S2 are sufficient for the ligand-binding activity
of AMPA receptors and can be produced as a separate, soluble S1S2 fusion protein
(this study). The LBD in AMPA receptors is monomeric when expressed as a soluble
construct (Chen and Gouaux, 1997; this study) indicating that the ligand binding site
may well reside within one subunit, in contrast to acetylcholine receptors, where the
ligand is thought to bind to a site formed between two subunits (Blount and Merlie,
1989). NMDA receptors have two kinds of agonist binding sites; the NR1 subunit
harbors the binding site for glycine, whereas the glutamate-binding site resides in the
NR2 subunit (Kuryatov et al., 1994; Laube et al., 1997).
Molecular modeling based on sequence alignments together with site directed
mutagenesis has been used to predict the residues involved in ligand binding (Kuryatov
et al., 1994; Hirai et al., 1996; Paas et al., 1996; Laube et al., 1997; Lampinen et al.,
1998). Key residues responsible for binding of ligand in AMPA receptors seem to be
equivalent to those in the bacterial PBPs; in particular, ionic interactions between the
α-carboxyl group and α-amino group of glutamate and oppositely-charged residues
in the receptor seem to stabilize the agonist in the binding site (Lampinen et al., 1998).
The crystal structure of the kainate-bound complex of GluRB LBD (Armstrong
et al., 1998) confirmed the close similarity between glutamate receptors and PBPs
predicted by earlier studies. The structure of S1S2 resembles a clam shell with a
slightly ellipsoidal (57Å × 43Å × 35Å dimensions) shape and the two lobes (called
lobes 1 and 2) have α/β secondary structure with 11 helices altogether. S1 and S2
contribute to both lobes as the polypeptide chain crosses over between domains. The
ligand binds in the interdomain crevice with mainly polar interactions mediated by
hydrogen bonds and essential ionic interactions. In the S1S2 domain there are three
cysteines, of which one is free and two form a disulfide bridge (Abele et al., 1998).
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This disulfide bridge is conserved in ionotropic GluRs and is a target for redox modulation
of NMDARs (Köhr et al., 1994; Sullivan et al., 1994). The disulfide bridge appears to
stabilize the open, unliganded conformation of the ligand-binding domain.
The mechanism of ligand binding to PBPs has been studied in some detail. It is
believed that the ligand first binds to lobe 1 with low affinity and subsequently establishes
interactions with lobe 2, which closes the domain and leads to high-affinity binding.
This mechanism has been termed the “Venus flytrap model” according to the well-
known botanical example (Sack et al., 1989). This mechanism has also been suggested
for the glutamate receptor ligand-binding domain based on the structural homology
(Mano et al., 1996). According to Mano et al., in GluRs the closure of the ligand-
binding site would lead to the desensitized state of the channel. This model predicts
substantial movements of the lobes leading to closure of the binding site. Such dramatic
movements of the lobes were not, however, observed with GluRs, in studies using
small angle X-ray scattering to measure the radius of gyration in the presence and
absence of glutamate (Abele et al., 1999). Furthermore, the GluR LBD contains a
disulfide bridge that is absent from the PBPs, giving further structural constraints.
Therefore, either the movement does not occur or it is so subtle, that it is difficult to
detect. Thus the ligand binding mechanism can not yet be established.
The N-terminal domain with ~400 amino acids (“X domain”, Fig. 5) comprises
around one third of the receptor protein, but has until recently been lacking any
functional role. No effect on agonist binding properties has been detected when this
domain has been swapped between different iGluRs or deleted (Stern-Bach et al.,
1994; this study), but reports concerning its function in allosteric regulation have
been published (e.g. Choi and Lipton, 1999; Masuko et al., 1999). In NMDA receptors,
this domain probably has sites for binding of regulatory compounds such as zinc,
spermine and the NMDAR antagonist ifenprodil. The voltage-independent zinc
inhibition of the NMDA receptor involves histidines His42 and His44 of the NR2A
subunit (Choi and Lipton, 1999). Ifenprodil, which selectively inhibits NR2B-
containing NMDA receptors, binds to a site distinct from the glycine and glutamate
sites in an activity-dependent manner. This site was located at least partly to the
proximal part of the NR1 amino-terminus by studying site specific mutations to the
N-terminal domain of NR1 (Masuko et al., 1999). Furthermore, the N-terminal domain
of NR2 subunits has been suggested to play a role in the glycine-independent
desensitisation of NMDA receptors (Krupp et al., 1998; Villarroel et al., 1998). NMDA
receptors have several forms of desensitisation, of which glycine-independent
desensitisation occurs in the presence of a saturating concentration of the co-agonist
glycine, but is independent of calcium influx.
The extracellular domain has also recently been proposed to have a role in the
oligomerisation of the protein (Leuschner and Hoch, 1999; this study). Chimaeric
and truncated subunits assemble into oligomeric receptors if the N-terminal
extracellular domain is present. Furthermore, the assembly is subtype specific, i.e.
AMPA and kainate receptors do not co-assemble (Leuschner and Hoch, 1999).
In addition to the aforementioned roles, the extracellular domain may interact
with proteins in the synaptic cleft. Recently, a secreted protein called neuronal activity–
regulated pentraxin (Narp) was shown to recruit AMPA receptors into large aggregates
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by interacting with the extracellular domains of AMPA receptors. (O’Brien et al.,
1999). Also, heparin, a sulfated glycosaminoglycan, has been suggested to interact
with AMPA receptors and modulate their single channel kinetics by prolonging the
mean open times (Sinnarajah et al., 1999).
Carboxy-terminal domain
The carboxy-terminal segment varies in size, constituting less than one-tenth
of the size of AMPA and kainate receptors as well as in NR1, while it forms
approximately one-third of the NR2 subunits. This segment is poorly conserved among
glutamate receptors and does not show obvious homology to other proteins. The C-
terminal region of glutamate receptors is intracellular (Fig. 5) and serves to anchor
the protein in the postsynaptic density (PSD) and to the signalling machinery. This
domain is also important for modulation of the receptor function, as it undergoes
alternative splicing and contains sites for phosphorylation.
Yeast two-hybrid screening has been used to identify interactions between
the cytoplasmic domain of GluRs and postsynaptic density proteins. For example,
PSD-95 (called also SAP90) has been shown to interact with the C-terminal seven
amino acids containing a tSXV motif in the cytoplasmic tails of NR2 subunits (Kornau
et al., 1995). PSD-95 harbors three so-called PDZ (PSD-95/Dlg/ZO-1) domains, which
interact with the NMDA receptor, a Src homology (SH3) domain and a guanylate
kinase (GK) homology domain. Several other proteins, which contain PDZ domains,
have been shown to interact with other GluR subunits, including AMPA receptors.
Glutamate receptor interacting proteins (GRIP 1 and 2, ABP) containing six to seven
PDZ-domains (Dong et al., 1997; Srivastava et al., 1998; Dong et al., 1999) and a
protein interacting with C kinase (PICK1, Xia et al., 1998), which has a single PDZ
domain, have been shown to physically interact with AMPA receptors and induce
clustering of AMPA receptors in excitatory synapses.
Kainate receptors are also associated with PDZ-domain harboring proteins
(Garcia et al., 1998). GluR6 associates specifically with the PDZ1-domain of SAP90,
SAP102, and SAP97 via its C-terminal ETMA sequence. GluR5 has a similar sequence
motif (ETVA) in its C-terminus, and may also interact with the SAP PDZ-domains.
Interestingly, KA-2 seems to interact with the SH3- and GK-domains of SAP90 and
SAP102 via its C-terminal PXXP-motif (Garcia et al., 1998).
The PDZ-domain containing proteins are capable of making multiple
interactions to form protein networks including cytoskeleton and signal transduction
molecules. The PDZ-domains can oligomerize in a hetero- or homomeric manner,
but the PDZ-domain containing proteins of AMPA and NMDA receptor-interacting
proteins do not bind to each other, which leads to separate clusters of AMPA and
NMDA receptors (Srivastava et al., 1998). The NMDA receptors appear to be more
firmly anchored to the cytoskeleton, whereas the AMPA receptors seem to be in a
more fluid context and thus may be more rapidly recruitable (Allison et al., 1998).
Activation of silent glutamatergic synapses has been proposed to occur via GluRB/C
interaction with GRIP/ABP leading to PKC-mediated signal transduction (Li, et al.,
1999). This results in more AMPA receptors being inserted into the postsynaptic
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membrane or activation of the already existing receptors by binding to PDZ-domain
containing proteins.
The N-ethylmaleimide-sensitive fusion protein (NSF), a hexameric ATPase
that plays a central role in general membrane fusion events, interacts with AMPA
receptors GluRB and GluRDc thus modulating AMPA receptor function (Nishimune
et al., 1998; Osten et al., 1998; Song et al., 1998). NSF interaction does not involve
PDZ-domains and the binding sites for GRIP and NSF in the C-terminal domain of
AMPA receptor subunits are overlapping and thus the two proteins may compete for
association with AMPA receptors. This might have a role in the turnover and
internalisation of the receptors upon synaptic plasticity (Luthi et al., 1999).
The physiological importance of the PDZ-domains has been studied in vivo
by constructing mice having C-terminal deletions in their iGluR subunits. Transgenic
mice carrying C-terminally truncated NR2 subunits are phenotypically similar to mice
with knock-out of the entire subunit (reviewed in Sprengel and Single, 1998). The
expression of the subunit is at the same level as in wild type mice and the emerging
channels are indistinguishable from wild type NMDA channels, but the amounts of
functional synaptic NMDARs are decreased. Mice carrying the 2B∆C-terminus
truncation die soon after birth. 2A∆C mice are viable but exhibit impaired synaptical
plasticity and 2C∆C mice display deficits in motor coordination. A possible explanation
for this phenotypic similarity is the lack of a physical linkage to intracellular
components. 2B∆C has been reported to result also in hindering of efficient clustering
and synaptic localisation of NMDA receptors (Mori et al., 1998).
In conclusion, intracellular interactions may provide a basis for the structural
and functional regulation of GluR expression; GluRs can be targeted to synapses in a
cell-type, developmental and use-dependent manner.
1.3.2. Diversity of glutamate receptors.
Assembly of glutamate receptor subunits into various combinations creates a
variety of functionally and structurally different glutamate receptors. Further diversity
is generated at the level of single glutamate receptor subunits by genetic mechanisms
and post-translational modifications. Genetical mechanisms include two steps in the
processing of pre-mRNA: RNA editing and alternative splicing, whereas protein
modification includes the addition of N-glycans, phosphorylation and palmitoylation.
1.3.2.1. mRNA editing
RNA editing is a newly identified genetic mechanism for changing gene-
specified codons and hence protein structure and function. In mammalian nuclear
mRNAs it was first found in intestinal apolipoprotein B mRNA (Powell et al, 1987).
Later, it was recognised in the serotonin-2C receptor (Burns et al., 1997) and K+-
channel (Patton et al., 1997) mRNAs. However, it is best documented and characterised
in glutamate receptors (Fig. 6A; reviewed in Seeburg et al., 1998). Sequencing of the
AMPA receptor subunit genes revealed that the arginine in the Q/R-site of GluRB is
not encoded genomically, but it is introduced by editing of a single nucleotide in the
precursor mRNA (Sommer et al., 1991). This Q/R site editing occurs also in the kainate
receptor subunits GluR5 and –6, but not in the other AMPA or kainate receptor subunits.
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Figure 6. Editing and alternative splicing of iGluR subunits. The membrane-embedded
segments are shown by blue boxes A. The editing sites are indicated for AMPA and kainate
receptor subunits. The NMDA receptor subunit mRNAs have not been found to be edited. B.
The alternatively spliced cassettes are shown for different iGluR subunits by the differentially
coloured boxes. (After Dingledine et al., 1999).
26
The editing of this site is controlled in a cell-type specific and developmental manner: in
the fetal rat brain both unedited and edited GluR-B forms exist, but at birth the GluRB
subunit is almost completely edited (99.9%, Burnashev et al., 1992). The GluR5 and 6
subunits seem to be less efficiently edited than GluRB (Köhler et al., 1993). The editing
determines the single-channel conductances of GluR5 and GluR6 channels so that the
edited versions exhibit 25- and 10-fold reduced conductances as compared to the
unedited GluR6 and GluR5, respectively (Swanson et al., 1996). In heteromeric kainate
receptors consisting of edited versions of either GluR5 or GluR6 and a KA-2 subunit
(harboring a glutamine at the Q/R site), the single-channel conductances are higher
than in the homomeric channels. GluRB editing also reduces single-channel conductance
in comparision to unedited GluRB (Swanson et al., 1997). Thus, the number of arginine
residues introduced by editing seems to determine the single-channel conductance.
Interestingly, the NR3A subunit of NMDA receptors is the only subunit having an
unedited arginine at the Q/R/N-site, i.e. an arginine is encoded genomically (Ciabarra
et al., 1995).
Two other editing sites were found in the M1 segment of GluR6: isoleucine
or valine at the I/V-site and tyrosine or cysteine at the Y/C-site (Köhler et al., 1993).
Thus, eight isoforms of GluR6 may exist: the genetically coded QIY (10% of rat brain
mRNAs), the fully edited RVC (comprising 65%) and six partially edited forms (25%
of total GluR6 mRNAs). The M1 editing also contributes to the Ca2+ -permeability of
the channel together with the Q/R site editing. Interestingly, it was found that if TM1
is fully edited, then the arginine at the Q/R site confers higher Ca2+-permeability than
glutamine does, in contrast to the AMPA receptors.
Yet another editing position was found in the extracellular S2-segment of
AMPA receptors; the mRNAs of subunits GluRB, -C and –D are edited, introducing
a glycine codon instead of an arginine codon (the R/G site, Lomeli et al., 1994). The
extent of editing is controlled in a cell-type and splice variant (see 1.3.2.2.) specific
manner and according to the developmental stage. The AMPA receptor channels edited
at the R/G site exhibit faster recovery from desensitisation and thus larger steady-
state currents too (Lomeli et al., 1994).
The mechanism of the glutamate receptor RNA editing appears to be via site
selective deamination of adenosine to inosine, occuring in the nucleus at the pre-
mRNA stage. The intronic sequences are vital for Q/R site editing. The editing enzyme
recognises a short double stranded RNA structure formed between an exonic sequence
around the editing site and a complementary sequence (ECS) in the downstream intron
(Higuchi et al., 1993; Egebjerg, 1994; Herb et al., 1996). Several editing enzymes are
now identified; these are called adenosine deaminases acting on RNA (ADAR 1-3;
reviewed by Bass et al. 1997). These enzymes are expressed in many tissues, and thus
the mechanism may be more widespread than originally anticipated.
RNA editing affects the channel properties of GluRs, and may therefore have
an important physiological role. This has been studied by making transgenic and a
knock-out mice incapable of editing GluRB subunits (Brusa et al., 1995; Feldmeyer
et al., 1999). Heterozygous mice harboring an editing-incompetent allele of GluRB
express unedited GluRB subunits and thus AMPA receptors with increased Ca2+-
permeability. These mice show epileptical seizures and die before postnatal day 20.
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Conversion of the high Ca2+-permeability exhibiting receptors into a low Ca2+-
permeability species at birth seems thus to be critical for expression of healthy
phenotype.
1.3.2.2. Alternative splicing
Glutamate receptor subunits exist in different molecular versions arising from
alternative splicing of pre-mRNAs. Splicing has been shown to occur in the N-terminal
domain, C-terminal domain and in the extracellular loop between M3 and M4
depending on the subunit (Fig. 6B). These splice variants add to the diversity of GluRs
by showing different functional properties and expression patterns.
In all AMPA receptor subunits, a module called “flip-flop” can be chosen
from two adjacent exons (exons 14 and 15) separated by an intron of ~900 bp (Sommer
et al., 1990). This 115 bp module encodes a 38 amino acid segment in the S2-domain.
The flip and flop cassettes are very similar, differing only in 9-11 residues. However,
the alternative flip and flop versions of the AMPA receptor subunits have distinct
expression patterns and different pharmacological and kinetic properties. The two
splice variants differ in the distribution and expression levels in rat brain. In the
hippocampus the cell specific nature of expression is clear; the flip form is the only
isoform in the pyramidal cells in the CA3 area, whereas in the CA1 area both forms
coexist (Sommer et al., 1990). The expression of flip- and flop-variants are also
developmentally controlled. Early in development, before postnatal day 8 the flip
form is the only form expressed, but after this stage the expression of the flop isoform
increases throughout the entire rat brain. By postnatal day P15 the adult-specific pattern
is established (Monyer et al., 1991).
The different functional characteristics of the flip and flop variants suggest
that splicing has a physiological role. The flip forms show slower desensitisation in C
and D subunits, but there is no difference in A and B subunits (Mosbacher et al.,
1994). Studies with modulatory drugs have shown that the flip and flop domains
differ in their pharmacological properties. Allosteric potentiators of AMPA receptors,
cyclothiazide and 4-[2-(phenylsulfonylamino)-ethylthio]-2,6-difluoro-phenoxy-
acetamide (PEPA), have opposing effects on the flip and flop isoforms of GluRA
receptors. The flip form is more potentiated by cyclothiazide that the flop form (Partin
et al., 1993). This difference was traced to a single residue, Ser750 on GluRAi, which
is replaced by asparagine in the corresponding site in GluRA
o 
(Partin et al., 1995 and
1996). Flop-forms, in contrast, are preferentially modulated by PEPA (Sekiguchi et
al., 1997).
In the X-ray structure of GluRB LBD, the flip/flop domain forms two adjacent
α-helices on the surface of the LBD (Armstrong et al., 1998). This suggests that it
may participate in the allosteric regulation of the channel by cyclothiazide and PEPA
by coupling the movements of the LBD upon binding of ligand to the opening of the
channel, possibly by mediating this signal to the transmembrane domains.
AMPA receptor subunits GluRB and D are further varied via alternative
splicing of mRNAs producing two different C-termini (Köhler et al., 1994; Gallo et
al., 1992).  These are produced by insertion of a module 14 amino acids downstream
from M4. The longer GluRB C-terminus shows similarity to the C-termini of GluRA
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and the longer GluRD. The shorter C-terminus of GluRB, on the other hand, is similar
to those of GluRC and the shorter GluRD. Curiously, with GluRA and C no splice
variants have been found. Expression of different splice variants varies across the rat
brain as studied by in situ hybridisation. The majority of native GluRD subunits carry
the longer C-terminus, whereas only a minor fraction of GluRB subunits contain the
longer C-terminus.
Kainate receptor mRNAs also undergo alternative splicing. In GluR5 an
insertion of 15 residues in the N-terminal domain generates two splice forms, GluR5-
1 and GluR5-2 (Bettler et al., 1990). In addition, GluR5 has three C-terminal splice
variants, which do not differ pharmacologically, but their expression levels are affected
in transfected cells (Sommer, 1992). Two GluR7 variants, known as 7a and 7b, diverge
after 14 amino acids downstream from M4 with a 40 nucleotide insertion resulting in
alternative C-termini (Schiffer, 1997). GluR7b C-terminus shows no homology to
other GluR sequences and exhibits smaller glutamate activated currents than 7a
(Schiffer, 1997).
In the NMDA receptor subunit NR1, three exons undergo alternative splicing.
Eight isoforms of NR1 are produced by combinatorial usage of three cassettes termed
N, C1 and C2 (Sugihara et al., 1992; Hollmann et al., 1993). The N-cassette encodes
21 amino acids that can be inserted in the N-terminal domain at residue 190. C1 and
C2 (37 and 38 amino acids, respectively) are coded by adjacent exons and can be
inserted into the C-terminal domain proximal to M4. Splicing-out of the segment that
encodes the C2 cassette removes the first stop codon and results in a new open reading
frame that encodes an unrelated 22-residue segment, C2’. The splice variant expression
pattern reveals regional differences that do not change in the course of development
despite changes in abundance (Laurie and Seeburg, 1994). The variants lacking the N-
cassette (a-variants) are uniformly expressed in rat brain, whilst the variants containing
the N-cassette (b-variants) are more restricted in expression. In primates the expression
pattern is similar (Meoni et al., 1998).
The NR1 a- and b-isoforms are also functionally different. The b-variants
exhibit larger current amplitudes and lower affinity for agonists, but greater affinity for
antagonists than the a-variants (Sugihara et al., 1992; Durand et al., 1992; Hollmann et
al., 1993). Low concentration of Zn2+ potentiates glutamate-gated currents at a-type
channels, but higher concentrations of Zn2+ are inhibitory to both a-and b-type channels
(Hollmann et al., 1993). The NR1 N-terminal splice variants also have different pH-
sensitivities; insertion of the N-cassette confers on the receptor lower sensitivity to
extracellular protons (Traynelis et al., 1995). A similar effect is seen with polyamines
as they attenuate proton inhibition suggesting that the N-cassette might modulate
NMDA receptor pH-sensitivity by interacting or shielding the extracellularly located
pH-sensor. The splicing of the C-terminal domain regulates surface expression of the
functional NMDA receptors (Ehlers et al; 1995; Okabe et al., 1999).
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1.3.2.3. Post-translational modifications
Glycosylation is a post-translational modification whereby carbohydrate chains
are covalently attached to serines (O-linked glycosylation) or asparagines (N-linked
glycosylation) of the proteins. Addition of glycans is part of the protein’s maturation
process, but its physiological functions are still poorly known. Glutamate receptors
harbor several potential sites for N-linked glycosylation in their extracellular domains
and several of these sites have been shown to be glycosylated in recombinantly
expressed glutamate receptor subunits (Roche et al., 1994; Taverna et al., 1994).
Intracellularly-located glutamate receptors have been reported to have simple, high-
mannose type oligosaccharides, thus representing an immature pool of receptors,
whereas the synaptic GluRs have complex, fully-processed sugar chains representing
the mature forms of receptors (Standley et al., 1998). The possible role of the
asparagine-linked glycans in receptor function is not clear at present. Glycans are not
necessary for the ligand binding activity as shown by native-like ligand binding activity
of the soluble AMPA receptor ligand binding domain expressed in Escherichia coli,
an organism not capable of glycosylation (Arvola and Keinänen, 1996). However,
treating cells with lectins such as concanavalin A (Con A), which binds specifically
to certain carbohydrates, potentiates currents elicited by glutamate, quisqualate and
AMPA possibly by reducing desensitisation, suggesting that the glycans have a
functional role (Mayer and Vyklicky, 1989). N-glycosylation has been shown to be
an absolute prerequisite for lectin–mediated inhibition of desensitisation, but the
specific site of lectin-binding does not appear to be important (Everts et al., 1997;
Everts et al., 1999).
The phosphorylation state seems to be an important modulator of glutamate
receptor activity. The alternatively spliced C-termini of glutamate receptors differ by
the presence of phosphorylation sites (Tingley et al., 1993; Barria et al., 1997; Grant
et al., 1998; Carvalho et al., 1999). Protein kinase C (PKC), cyclic AMP-dependent
protein kinase (PKA) and Ca2+-calmodulin dependent protein kinase II (CaM-KII)
have been reported to phosphorylate serine and threonine residues in GluR subunits
in a sequence context-dependent manner. Phosphorylation has been observed after
induction of LTP, and CaM-KII activity has been shown to be necessary and sufficient
for LTP (Barria et al., 1997, Pettit et al., 1994).
Palmitoylation, the covalent addition of fatty acid chains to a serine, threonine
or cysteine residue in proteins via an ester or thioester bond, is one well-characterised
post-translational modification, which also occurs in glutamate receptors. In GluR6,
palmitoylation occurs at two cysteines (C827 and C840) located in the C-terminal
domain, but this modification does not change the kainate-gated currents (Pickering
et al., 1995). However, an unpalmitoylated mutant GluR6 was reported to be a better
substrate for protein kinase C than the wild type palmitoylated receptor, suggesting
that palmitoylation may indirectly modulate receptor function.
1.3.3. Assembly of glutamate receptors
Glutamate receptors, like other known ion channels, are oligomeric proteins
consisting of homologous subunits. Whilst the subunit composition of GluRs can
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vary with cell type and stage of development leading to different functional properties,
the subunits always assemble subtype specifically. Thus, e.g. AMPA receptor subunits
can co-assemble from different combinations of GluRA-D subunits, but they do not
make complexes with the kainate or NMDA receptor subunits (Partin et al., 1993;
Puchalski et al., 1994).
The number of subunits is considered to be a well-conserved property within a
given channel protein family. Thus, voltage-gated potassium channels are known to be
tetramers, whilst muscle nicotinic acetylcholine receptors and other members of the
acetylcholine receptor superfamily are pentameric (Doyle et al., 1998; Unwin 1995).
Currently, the actual number of subunits in a multimeric glutamate receptor and the
stoichiometry (the relative proportions of each subtype) is not known, nor have the
determinants of assembly been identified. Being neurotransmitter receptors, glutamate
receptors were initially thought to structurally resemble the pentameric acetylcholine
receptors. The superficial similarity between the pore structures of tetrameric potassium
channels and iGluRs suggests, however, that iGluRs might be composed of four subunits
instead. Biochemical analysis of native receptors by using either hydrodynamic analyses
or cross-linking are consistent with tetra- or pentameric assemblies for NMDA and
AMPA receptors (Wenthold et al., 1992, Blackstone et al., 1992, Brose et al., 1993,
Wu and Chang, 1994, Wu et al., 1996). Using native brain in cross-linking experiments
material is problematic, however, because interacting proteins may co-purify with the
receptors. Recently, the stoichiometry of recombinant and native NMDA receptors
has been studied by successive immunoaffinity purifications. The receptor was suggested
to contain at least three NR2 subunits and two NR1 subunits, thus having a pentameric
structure (Hawkins et al., 1999).
Furthermore, functional studies of the receptor have been carried out to find
out the number of subunits forming an ion channel. Modeling of single channel current
patterns (Behe et al, 1995, Prenkumar and Auerbach, 1998, Rosenmund et al., 1998)
and whole cell currents in hybrid receptors consisting of various proportions of mutant
and wild type subunits (Ferrer-Montiel and Montal, 1996, Laube et al., 1998, Mano and
Teichberg, 1998) have been employed. Assuming that two glutamate molecules are
needed for channel activation (Clements et al. 1998; Rosenmund et al. 1998) and that
single channel currents become larger when more glutamate is bound, it can be
calculated how many binding sites are occupied (Rosenmund et al., 1998). However,
the results obtained with these methods also segregate into two classes suggesting
tetra- or pentameric assemblies.
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1.4.  AIMS OF THE STUDY
The aim of this study was to characterise the structure-function relationships in AMPA
receptor subunit GluRD and in kainate receptor subunit GluR6 in order to gain
information on the molecular structure of ionotropic glutamate receptors and to establish
methods for direct structural analysis of iGluRs.
The specific goals of the study were
1) to develop a method for efficient purification of recombinant glutamate receptors
2) to identify and analyse the ligand-binding site in AMPA and kainate receptors
3) to study the properties of the ectodomain of GluRD AMPA receptor
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2. MATERIALS AND METHODS
The materials and methods are described in the original publications and
therefore only a list of methods is provided here.
Method Original publication
Baculovirus expression system I-IV
Chemical cross-linking IV
Fluorescence titration IV
Gel filtration chromatography IV
Immobilised metal ion affinity
Chromatography -intact GluRD
I
Immobilised metal ion affinity
Chromatography -soluble domains
IV
Immunoaffinity chromatography
-membrane proteins
I
Immunoaffinity chromatography
-soluble proteins
II
Immunoprecipitation IV
Insect cell culture I, II
Protein assay, BCA I
Protein assay, amido black I
Radioligand binding assay
[3H]AMPA
I-IV
Radioligand binding assay
[3H]Kainate
III
Recombinant DNA I-IV
SDS-PAGE I
Solubilisation of GluRD I
Stopped-flow kinetics IV
Sucrose density gradient centrifugation IV
Western blotting I
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3. RESULTS
3.1. EXPRESSION OF RECOMBINANT NON-NMDA RECEPTORS (I AND III)
Glutamate receptors are not abundant in native nervous tissue, therefore
recombinant expression is necessary to produce sufficient amounts of homogenous
material for detailed biochemical, biophysical and structural analyses. In the present
study, homomeric GluRs, consisting of an AMPA selective GluRD subunit or a kainate
selective GluR6 subunit, were expressed in insect cells providing a source of
homogeneous material with a defined subunit composition.
Recombinant baculoviruses were prepared for expression of GluRD or GluR6.
The constructs were engineered to harbor an N-terminal FLAG tag and a C-terminal
His tag to facilitate identification and purification. Sf21 insect cells were infected, in
spinner flasks, with the recombinant viruses and cells harvested 3-4 d post-infection.
Membranes from Sf21 cells infected with GluRD were prepared and tested for
expression of the receptor protein by SDS-PAGE followed by immunoblotting.
Detection with α-FLAG tag antibody showed a 110 kDa band representing the GluRD
subunit, with no visible degradation products (IV, Fig. 2A, lane 1), whilst uninfected
control cells or cells infected with wt AcNP virus showed no staining (not shown).
The immunopositive samples also showed specific binding of radioligand [3H]AMPA.
Characterisation of the binding properties revealed high-affinity [3H]AMPA-binding
(Kd = 40 nM, I) for membranes of GluRD-infected cells. In ligand competition assays,
the membranes showed typical AMPA selective pharmacology; the 50% inhibitory
concentrations (IC50) for agonists were 61 nM for AMPA, 390 nM for L-Glu and 2.2
µM for kainate. NMDA did not displace [3H]AMPA binding. The expression level
was 2-6 nmol (0.2-0.6 mg) from a liter of insect cell culture. The properties (affinity
and expression level) obtained here were similar to those obtained previously for the
untagged GluRD expressed in insect cells (Keinänen et al., 1994).
A kainate receptor GluR6 with an N-terminal FLAG-tag and a C-terminal
His-tag was also expressed in Sf21 cells. The membranes prepared from these cells
expressed a 100-112 kDa broad band typical for glycoproteins, with a smaller, ~50
kDa band possibly representing a degradation product (III, Fig. 3B, lane 1). The
membrane preparation bound [3H]kainate with high affinity (Kd = 18 nM). In ligand
competition assays, the agonists domoate (IC50 = 13 nM) and L-glutamate (IC50 = 0.6
µM) and the antagonist CNQX (IC50 = 3.8 µM) inhibited binding, whereas AMPA
and NMDA did not. These binding properties were similar to those described earlier
for mammalian cell-expressed GluR6 (Egebjerg et al., 1991; Sommer et al., 1992).
Hence, it is feasible to produce recombinant glutamate receptors in insect
cells for structural studies. The recombinant receptors resemble the wild type receptors
expressed in mammalian cells.
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3.2.  PURIFICATION OF RECOMBINANT AMPA RECEPTORS (I)
To obtain material for structural studies of AMPA receptors, solubilisation
and purification of recombinantly expressed homomeric GluRD receptors were studied.
Solubilisation of insect cell membranes expressing GluRD harboring an N-
terminal FLAG tag and a C-terminal His tag was studied using different detergents.
Glycerol and the protease inhibitor phenylmethylsulfonyl fluoride (PMSF) were included
in the solubilisation buffer for better preservation of the activity of the protein. After an
overnight solubilisation at +40C, the mixture was clarified by high speed (160 000 × g)
centrifugation for one hour to get rid of all insoluble material. The efficiency of
solubilisation was followed by measuring [3H]AMPA binding activity in the supernatant
before and after adding the detergent. The non-ionic detergents Triton X-100, Triton
X-114, n-octyl-D-glucoside and n-dodecylmaltoside were most efficient in solubilising
GluRD. The concentration dependence of GluRD solubilisation in Triton X-100 was
tested and 1% of the detergent was found to be sufficient, with no further solubilisation
obtained with higher concentrations of Triton X-100. Under optimal conditions, 60-
70% of the [3H]AMPA binding activity was solubilised with 1% Triton X-100.
Solubilisation did not affect the ligand binding properties.
Purification was carried out using a two-step protocol. As the first step,
immobilised metal ion affinity chromatography (IMAC) was employed. In preliminary
experiments, several divalent ions (Ni2+, Zn2+, Co2+, Cu2+) were tested for binding of
solubilised GluRD and best results were obtained with Ni2+. The bound receptors
were eluted from Ni2+ loaded Sepharose by using a rising imidazole step gradient. At
imidazole concentrations under 50 mM most of the nonspecifically or weakly bound
contaminating proteins were eluted, but the His-tagged GluRD eluted at 100 mM
imidazole, as judged by immunoblots and [3H]AMPA binding assay. As a second
purification step, an immunoaffinity column with monoclonal antibody M1 against
the FLAG tag was used. The recognition of the epitope is Ca2+-dependent, and thus
mild conditions for elution can be achieved by using EDTA. Pooled imidazole eluates
from IMAC were subjected to M1 immunaffinity chromatography in the presence of
1 mM Ca2+. The receptor was eluted with 2 mM EDTA. In a silver-stained protein gel,
a major 110 kDa band representing the purified GluRD was seen with a very faint
band of ~70 kDa representing contaminants or breakdown products (I, Fig. 6B).
Treatment with N-glycosidase F reduced the size of the purified protein from
110 kDa to 100 kDa indicating that purified GluRD is N-glycosylated. The purified
GluRD showed high-affinity [3H]AMPA binding (Kd = 40-60 nM) and the ligand
binding characteristics were unaltered by purification. The preparations showed specific
binding capacities of 1000-2900 pmol/mg, corresponding to a 50- to 100-fold
purification over the membrane preparations. The yields were 10-20% of the receptor
originally in the cells, resulting in 50-100 µg from a liter of suspension culture.
Two-step affinity chromatography based on engineered tags can thus be used
to purify recombinant AMPA receptors into essential homogeneity.
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3.3. IDENTIFICATION OF THE GLUR LIGAND BINDING SITE (II AND III)
When this study was initiated, the membrane topology of glutamate receptor
subunits was unsolved and very controversial. In particular, this concerned the location
of the loop segment between M3 and M4. This loop (S2) had been suggested to
participate, together with another segment (S1) in the ligand binding (Stern-Bach et al.,
1994). On the other hand, the extracellular location of the segment was questioned by
studies identifying phosphorylation sites in this segment (Wang et al., 1993; Raymond
et al., 1993; Yakel et al., 1995). To identify whether this loop together with S1 actually
participates in ligand binding, a clearly extracellular event, a dissection of two subunits,
GluRD and GluR6, representing two subtypes, was carried out (II and III).
We designed a series of constructs of the proposed extracellular portions of
the AMPA receptor subunit GluRDflip (II, Fig. 1a). These were the N-terminal domain
down to the first transmembrane segment (D/XS1, amino acids 22-546), the first and
second bacterial periplasmic binding proteins (PBPs) homology segments (D/S1, aa
404-546 and D/S2, aa 649-813) both separately and as a fusion protein (D/S1S2). The
N-terminus for S1 was determined from sequence alignments with LAOBP, HisJ and
QBP (alignment in Sun et al., 1998; structures in Kang et al., 1991 for LAOBP; Oh et
al., 1994 for HisJ; Sun et al., 1998 for QBP). The C-terminus of S1 and the N-terminus
of S2 correspond to borders with membrane-associated segments. To obtain a fusion
protein of the S1 and S2 segments of GluRD, we included a hydrophilic linker to
provide flexibility and to possibly aid in folding. This linker is a 12 amino acid peptide
from the membrane-bound form of IgM in which it connects the Cµ4 domain of the
immunoglobulin heavy chain to the hydrophobic transmembrane domain (Rogers et
al., 1980). To the N-terminus we included a GluRD signal sequence for secretion into
the culture medium and a FLAG tag, and to the C-terminus a c-myc-epitope for
identification and purification purposes. The receptor fragments were expressed in
High Five insect cells, since this cell line secretes proteins efficiently (Davis et al.,
1992). The culture media were harvested 3-4 d post-infection and tested for expression
of tagged constructs by immunoblotting. The XS1 fragment was secreted into the
culture medium as a 66 kDa band and was detected in the supernatant (II, Fig. 1B).
This is slightly higher than the molecular mass expected from the sequence (60 kDa)
and is probably due to the addition of N-glycans. The S1 (electrophoretic size 22/
expected size 17 kDa) and S1S2 (42/39 kDa) fragments were similarly secreted. The
S2 fragment (22/20 kDa), in contrast, was poorly secreted into the culture media and
accordingly, only a weak myc-immunoreactive band was observed in the supernatant.
The positive supernatants were subjected to high-speed centrifugation (160 000 × g)
to remove insoluble material. After extensive dialysis of the conditioned culture media
to remove all glutamate present, the samples were tested for radioligand binding. The
XS1 and separate S1 and S2 proteins were negative for [3H]AMPA-binding, as was a
control supernatant of cells infected with wild type viruses, but the S1S2 construct
showed consistent binding 10-40 times over the background.
The soluble S1S2 construct was purified in one step by using immunoaffinity
chromatography. Culture supernatant was passed through an anti-FLAG-tag antibody-
Sepharose column and the bound proteins were eluted with EDTA. A western blot
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analysis revealed a single 42 kDa species detected by monoclonal antibodies
recognising the FLAG and c-myc epitope tags. In a typical purification, the specific
binding capacity was 6-12 nmol/mg. The highest binding capacity obtained, 12.8
nmol/mg, corresponds to ~50% of the theoretical maximum, assuming one binding
site per S1S2 molecule.
The ligand-binding pharmacology of S1S2 was characterised in detail by using
displacement assays and compared to GluRDflip. The purified S1S2 bound [3H]AMPA
with high affinity (Kd = 50 nM) and competing ligands displaced this binding with a
profile typical for AMPA receptors (Honore et al., 1988; Keinänen et al., 1990). The
rank order of potencies was quisqualate (IC50= 33 nM) >L-glutamate (IC50= 0.38 µM)
≅DNQX (IC50= 0.46 µM) >kainate (IC50= 19 µM). NMDA (100µM) did not affect
[3H]AMPA binding of D/S1S2. These values are close to the values obtained for
intact GluRD (II, Fig 3b). Thus, D/S1S2 reproduces the binding characteristics of
membrane-bound GluRD and both S1 and S2 are needed for high-affinity agonist and
antagonist binding.
To further confirm the results and to study if the ability of the S1 and S2
domains to form a ligand binding site independent of the rest of the protein is a general
property of glutamate receptors, a similar ligand-binding fragment was constructed
for the kainate receptor GluR6 (III). A fragment, 6/S1S2 (amino acids 407-561/662-
819), was constructed with the same molecular characteristics as D/S1S2. Thus it had
an EGT (AcNPV ecdysone-S-glycotransferase) signal sequence, the same linker
segment as in D/S1S2 and an N-terminal FLAG tag. In the C-terminus a His tag was
included. The construct was produced in High Five insect cells as a secreted protein
with an electrophoretic size of 43-54 kDa. The culture supernatant was centrifuged
and dialysed extensively to remove endogenous glutamate and tested for [3H]kainate
binding. No specific binding was, however, observed.
In parallel, GluR6 fragments, which retained some of the membrane associated
segments, were analysed. Two deletion mutants were constructed, one which lacks
the X-domain and the segment C-terminal from S2 (S1[M1-M3]S2, aa 407-819) and
another, which lacks the N-terminus until S1 and the membrane domains M1-M3, but
contains an intact C-terminus from S2 fragment (S1S2-M4, aa 407-561/662-908; III,
Fig. 3a). These were expressed in High Five cells, the cells were harvested 3 days post
transfection and examined for expression of recombinant constructs by
immunoblotting. Diffuse or multiple bands with a size range of 48-60 kDa (S1[M1-
M3]S2) and 54-60 kDa (S1S2-M4) were observed.  The membrane fraction was isolated
and studied for kainate binding. These membranes consistently bound [3H]kainate
and the binding was displaced with 1 mM L-glutamate. The ligand binding
characteristics of S1[M1-M3]S2 were characterised further. This membrane-bound
fragment bound [3H]kainate with high affinity (Kd = 15 nM). The binding was displaced
by domoic acid (Ki = 6 nM), L-glutamate (Ki = 0.8 µM) and CNQX (Ki = 1.2 µM).
100 µM AMPA or L-glutamate did not affect binding. These characteristics were
similar to intact GluR6.
Since the membrane anchors in the two fragments (S1[M1-M3]S2 and S1S2-
M4) were different, but both were able to render the fragments functional in terms of
high-affinity [3H]kainate binding, a possibility emerged that anchorage to a support
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may  be needed for functionality. Therefore, the kainate-binding assay was modified
so that the S1S2 fragment was first bound to a Ni2+ chelating Sepharose matrix and
then incubated with the radioligand and subjected to a filtration assay. Using the
modified assay, GluR6/S1S2 exhibited consistently specific [3H]kainate binding
activity. It did not bind [3H]AMPA, nor did the Sepharose beads without 6/S1S2 or
beads with D/S1S2 bind any [3H]kainate. In spite of the specificity, however,
[3H]kainate binding was of relatively low affinity (Kd = 300-400 nM), although accurate
values were difficult to obtain because the binding did not saturate at the radioligand
concentrations up to 300nM. In a competition assay, domoate displaced [3H]kainate
with IC50 value of 0.33 µM; L-glutamate inhibited binding with an IC50 value of 15
µM and CNQX with IC50 of 4.5 µM. Compared to intact GluR6, the affinities for the
agonists kainate, domoate and glutamate were ~20-fold lower, but the affinity towards
the antagonist CNQX was similar.
These results show that S1 and S2 form the ligand-binding site in GluR6 and
that the binding site can be expressed as a S1S2 fusion protein in insect cells. The
ligand-binding properties of GluR6, however, are not as closely reproduced by the
S1S2 fragment as those of GluRD. In 6/S1S2 the affinity for agonists is reduced,
whilst the affinity for the antagonist CNQX is similar to membrane-bound GluR6.
Binding of [3H]kainate can be measured in the presence of an artificial support, but
affinity is still lower than in the intact GluR6.
3.4. DETERMINANTS FOR LIGAND SELECTIVITY (III)
The two ligand-binding domains from different subtypes of the glutamate
receptors, GluRD/S1S2 and GluR6/S1S2, bind their respective ligands specifically,
i.e. D/S1S2 binds [3H]AMPA but not [3H]kainate and 6/S1S2 binds [3H]kainate but
not [3H]AMPA. The structural determinants for ligand selectivity between AMPA
and kainate receptors must therefore lie within the ~300 amino acids in the segments
S1 and S2.
The relative roles of the S1 and S2 segments in ligand selectivity were studied
with soluble chimaeric ligand binding domains. The chimaeras were generated between
an AMPA selective GluRD/S1S2 and a kainate selective GluR6/S1S2 (III, Fig. 6).
The chimaeric S1S2 fragments were expressed in High Five insect cell cultures, and
were secreted into the culture medium. The culture supernatants were harvested 3-4
days post-infection and examined for radioligand binding. Binding of [3H]AMPA
was assayed from samples dialysed against the binding buffer. [3H]kainate binding
activity was determined with a modified ligand binding assay described above.
First, intact S1 and S2 segments were exchanged. The construct having the
S1 segment from GluR6 and the S2 segment from GluRD (6/S1:D/S2) bound both
[3H]AMPA and [3H]kainate in a single-point radioligand binding assay, whereas the
reverse chimaera D/S1:6/S2 bound neither of the radioligands. Second, further
chimaeras within the S2 segment were constructed. A 61 amino acid segment at the
N-terminus of 6/S2 was replaced with the corresponding part of D/S2. This was joined
with either D/S1 or 6/S1. The chimaera D/S1:D6/S2 bound [3H]AMPA, but not
[3H]kainate. In contrast, the chimaera 6/S1:D6/S2, where the only part derived from
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GluRD is the 61 amino acid segment in S2, bound both radioligands. A further
minimisation of the contribution of GluRD by replacing only 32 residues at the N-
terminus of S2 in 6/S1S2 resulted in protein that was secreted, but did not have any
ligand binding activity. The chimaera 6/S1:D6/S2 was studied in more detail by using
saturation-binding and ligand-competition assays. The affinity for AMPA was too
low to be measured accurately, with a Kd value > 200 nM. L-glutamate, kainate and
CNQX displaced [3H]AMPA with IC50 values of 0.07 µM, 0.37 µM and 1.3 µM,
respectively. The affinities for AMPA and CNQX were lower than in GluRD/S1S2,
but the affinities for glutamate and kainate were higher than in GluRD/S1S2.
The results suggest that the N-terminal one-third of S2 contains some important
residues for selective AMPA binding, as it alone is able to confer AMPA binding
ability to 6/S1S2.  The chimaeras were all secreted and water soluble, since they
remained in solution upon centrifugation at 160 000 × g. In the construct D/S1:6/S2
there is some structural incompatibility that does not allow the binding of ligands to
the binding pocket.
3.5. BIOCHEMICAL CHARACTERISATION OF THE ECTODOMAIN (IV)
Encouraged by the successful production of the ligand-binding domain as a
separate S1S2 fusion protein, we extended this approach to the whole ectodomain and
to the N-terminal ~400 amino acids. Importantly, not much is known of the structure
and function of the N-terminal domain (X domain) and therefore, this domain is of
special interest.
First, we investigated whether the ectodomain and the X domain could be
produced as soluble, secreted proteins. This would facilitate their more detailed
analysis, and eventually, would serve as the first step towards their crystallisation.
Recombinant GluRD constructs were designed to express the extracellular
domains as affinity-tagged proteins. The N-terminal part of the receptor up until the
M1 segment (XS1, amino acids 22-546), the first 381 residues (X, aa 22-403), the
S1S2 domain harboring the S1 segment before M1 and the loop between M3 and M4,
and the whole extracellular part (XS1S2, aa 22-546/649-813) were expressed in High
Five insect cells as immunoreactive proteins of expected sizes and were secreted into
the culture medium (IV, Figs. 1 and 2). The fragments were purified from the culture
supernatants using metal chelation chromatography.  In silver stained protein gels
one major band was seen, with no contaminating protein bands. The XS1 fragment
was the most susceptible one of the fragments to degradation, with proteolytic products
appearing after some weeks of storage on ice. The yields were 100-400 µg of purified
XS1S2, XS1 and X and 1-2 mg of S1S2 from one-liter cultures.
The purified proteins were analysed for binding of [3H]AMPA and L-
[3H]glutamate in a filtration assay. As shown earlier (Stern-Bach et al., 1994; II and
III), the segments S1 and S2 are necessary for high-affinity ligand binding. Consistent
with this, XS1S2 and S1S2 fragments exhibited specific binding of the radioligands,
whilst XS1 and X did not. In a saturation binding assay, the purified XS1S2 bound
AMPA with a Kd value (42nM) very similar to that of S1S2 (Kd =33nM) and intact
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GluRD (Kd = 58nM). In ligand displacement assays, AMPA binding was displaced by
L-glutamate (IC50= 0.28µM), kainate (IC50= 2.1µM) and DNQX (IC50= 0.23µM) with
IC50 values similar to those obtained for S1S2 (respective IC50 values were 0.29µM,
2.3µM and 0.46µM) and intact GluRD (respective IC50 values were 0.45µM, 3.1µM
and 0.58µM; IV, Table I). The filtration assay is sensitive to the ligand off-rate and to
obtain more accurate binding parameters and to establish the kinetics of binding,
fluorescence-based ligand binding measurements were done. These are based on the
quenching of tryptophan fluorescence upon conformational changes induced by binding
of the ligand. The quenching effect can be titrated with ligand to obtain binding
affinities. The S1S2 and XS1S2 show similar affinities for L-glutamate, with Kd values
of 0.55 µM and 0.49 µM, respectively. These values are somewhat higher, but similar,
to the ones obtained from filtration assay (0.29µM for S1S2 and 0.28µM for XS1S2).
Finally, the time course of glutamate-induced fluorescence changes was
followed by using stopped-flow rapid-mixing techniques. Under pseudo-first order
conditions ([L]>>[R]), the observed rate constant exhibited linear dependence on
glutamate concentration. The association and dissociation rate constants showed no
significant difference for S1S2 and XS1S2, with k
on
= 16 × 106 M-1s-1, k
off= 8 s-1 for
S1S2 and k
on
= 15 × 106 M-1s-1, k
off= 6 s-1 for XS1S2 (IV, Table II).
Because XS1S2 is able to bind AMPA and L-glutamate with high affinity, the
structure of the X domain in it is probably close to native. For the X domain expressed
without S1S2 there are no functional assays. Therefore, the integrity of its structure
has to be studied by other means. A recently isolated monoclonal antibody, Fab21,
binds to an epitope within the X domain in a conformation-specific manner (Jespersen
et al., 2000). Immunoprecipitations with Fab21, were carried out for the soluble
fragments. All of the fragments containing the X domain (XS1S2, XS1 and X) were
immunoprecipitated by Fab21, but S1S2 was not. As a control, the X domain was
heated briefly at 65oC and denatured. This was not immunoprecipitated by Fab21,
thereby verifying the conformation-specificity of the antibody. Thus, the X domain
seems to fold correctly when produced as a secreted, soluble construct.
To study the oligomeric state of the fragments, their native molecular weights
were determined. These can be calculated from the Svedberg equation (Eq. 1) if the
diffusion (D) and sedimentation constants (s) are known. These hydrodynamic
parameters can be determined from size exclusion chromatography (àD) and sucrose
density gradient centrifugation (às),
  sRT
 M= (Equation 1)
D(1-υρ)
where s is the sedimentation coefficient, R is the gas constant (8.314 JK-1 mol-1), T is
the absolute temperature (293 K), D is the diffusion coefficient, υ is partial specific
volume estimated from the amino acid sequence and ρ is the density of solvent (for
water ρ= 0.9982 g cm-3).
In size exclusion chromatography, X and S1S2 eluted as single symmetric
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peaks, whereas XS1S2 exhibited a broader peak with a shoulder. XS1 eluted in the
void volume suggesting that it was aggregated and there was also a substantial loss of
protein with XS1 suggesting adsorbtion to the gel matrix. Therefore, it was not analysed
further. The peak fractions were assayed for radioligand binding and aliquots were
run on SDS-PAGE with subsequent immunoblotting. The silver stained and FLAG
immunoreactive receptor bands coincided with the peak fractions of A280 indicating
that these fractions correspond to the recombinant fragments. The diffusion coefficients
were obtained from a calibration graph in which the partition coefficients (derived
from elution volumes) of standard proteins were plotted as a function of the inverse of
diffusion coefficients, obtained from the literature (Sober, 1970).
In sucrose gradient centrifugation, S1S2 sedimented in a rather narrow band,
and X and XS1S2 in slightly more broad bands. The sedimentation coefficicients
were obtained from a calibration graph in which the distance of sedimentation of
standard proteins was plotted against the sedimentation coefficients found in the
literature. The values of D and s were used with the Svedberg equation to obtain the
following results:
The calculated sizes were derived from the amino acid sequences and do not
include glycans. The native molecular weights suggest that S1S2 is a monomer, whereas
X and XS1S2 are dimers in solution. The similarity between the experimental and
calculated size of S1S2 is very close and speaks for the general reliability of the
method.
To further analyse the oligomerisation states of X and XS1S2, cross-linking
experiments were carried out. Covalent cross-linking was achieved with glutaraldehyde,
which converted XS1S2 in a time- and concentration dependent manner into a larger
molecular weight complex (Mw around 160-200 kDa). Under the same conditions,
S1S2 remained exclusively monomeric (Mw = 42 kDa) and X produced a weak 100
kDa band in addition to the major 50 kDa band. These findings are consistent with the
monomeric and dimeric structures of S1S2 and XS1S2, respectively, as indicated by
the above hydrodynamic analysis. The dimerisation of the X fragment is, however,
more difficult to reconcile with the low level of cross-linked product. In SDS-PAGE,
after sucrose gradient centrifugation, the cross-linked XS1S2 was resolved into three
populations: monomers, dimers (majority) and a minority of much larger aggregates
that did not penetrate into the running gel (IV, Fig. 7B). As the cross-linked XS1S2
fragment sedimentated as a similar broad band as before glutaraldehyde treatment,
the cross-linking did not change its properties and thus it can be concluded that the
cross-links are intramolecular and not intermolecular. The dimer size band (160-200
kDa) constitutes the major population, hence proving that the XS1S2 exists in solution
D
(×107 cm2 s-1)
s
(×10-13)
Native mol.
mass
(kDa)
Calculated size
(kDa)
S1S2 6.85 3.0 41 38
X 5.65 5.3 86 46
XS1S2 3.61 6.7 169 82
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largely as dimers.
From these experiments it can be concluded, that it is feasible to produce
fragments of the extracellular parts of glutamate receptors as separate, soluble domains
in a structurally-relevant native-like state. In addition, the hydrodynamic size
measurements indicate that the separately expressed ectodomain exists as a dimer,
and that the dimerisation is determined by the presence of the X domain.
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4.  DISCUSSION
4.1. PURIFICATION OF A MEMBRANE BOUND CHANNEL PROTEIN
The glutamate receptors, unlike the nicotinic acetylcholine receptors, are not
abundant in any native tissue. Native glutamate receptors have, however, been
solubilised, purified and preliminarily characterised from various sources such as
pig, chick and rat brain (Chang et al., 1991; Henley and Barnard, 1989; Bahr et al.,
1992). The small amounts of receptor obtained from these sources have proved
insufficient for any detailed biochemical or particularly biophysical studies, which
typically require milligram amounts of highly homogeneous protein. Furthermore,
the glutamate receptors in nervous tissue are mostly heteromeric and often associated
with other proteins, which further complicates their molecular characterisation.
Heterologous expression systems provide the possibility to overexpress recombinant
receptors with defined composition for structural analysis.
Glutamate receptors have been expressed in Xenopus oocytes (e.g. Hollmann
et al., 1989), in transiently (Keinänen et al., 1990) and stably (Tygesen et al., 1994;
Andersen et al., 1996) transfected mammalian cells and in yeast cells (Becker et al.,
1998). Apart from yeast, these systems are not suitable for the large-scale biochemical
analysis of the receptor. In contrast, insect cells have proved easy to cultivate in large-
scale suspension cultures in relatively inexpensive serum-free media. Importantly,
insect cells are also able to express mammalian proteins with post-translational
modifications such as N-glycosylation, although differences in the glycans have been
reported (Ogonah et al., 1996). Most commonly, infection by recombinant baculovirus
is used to make the insect cells produce heterologous proteins.
In this study, homomeric GluRD AMPA receptors and GluR6 kainate receptors
were produced in Sf21 insect cells, and a purification method for the GluRD receptors
was established. The receptors were solubilised with a nonionic detergent Triton X-
100, which solubilised 40-60% of the homomeric GluRD receptors. No changes were
observed in the ligand binding properties of GluRD upon solubilisation. It has been
reported that solubilisation converts the low affinity pool of AMPA receptors into a
high affinity state (Hall et al., 1992), but in the present study the solubilised GluRD
receptors exhibited a similar affinity to [3H]AMPA as did the membrane bound GluRD.
Native glutamate receptors solubilised from brain tissue have been partially
purified by using various chromatographic methods such as ion exchange, lectin- and
hydroxyapatite chromatography (Chang et al., 1991; Hunter and Wenthold, 1992).
The optimal purification method would use affinity chromatography with a specific
ligand bound to a column to ensure that only active material would be recovered.
However, for glutamate receptors no such ligands are available. We decided to use
affinity tags engineered into the receptor subunits to facilitate the use of a similar
purification protocol for all recombinant receptors (I). A 5×His tag was engineered at
the carboxy-terminus and a FLAG tag at the amino-terminus of GluRD. These tags
did not affect the expression or solubilisation properties as compared to the wild type
receptors characterised earlier (Keinänen et al., 1994). The first purification step uses
immobilised metal chelation affinity chromatography and the second step
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immunoaffinity chromatography. Yields were typically 50-100 µg from a litre of insect
cell culture (2x106 cells). A purification of 50 to 100-fold was achieved with a specific
activity of 2000 pmoles of active receptor/mg of protein obtained in a successful
purification. Both the yield and specific activity of the purified receptors compare
favourably to values reported in the literature, including 370 pmol/mg of AMPA receptors
from bovine brain (Hunter and Wenthold, 1992) and 53 pmol/mg AMPA receptors
from rat brain (Bahr et al., 1992).
The ligand binding properties of the purified receptor were not different from
the membrane-bound or solubilised receptor. The best preparations had a specific
binding capacity of 2000 pmol/mg, which represents 20% of the theoretical maximum,
assuming one binding site/100kDa subunit. This can be interpreted so that 80 % of the
receptors are inactive or that in multimers only part of the subunits diplay high-affinity
binding. In addition, the determination of B
max
 may not be accurate, because in a
filtration binding assay the binding sites may not be recovered quantitatively. KSCN,
a chaotropic ion, was included in the binding-assay buffer as it had been reported to
convert AMPA receptors into a high-affinity state (Honore and Drejer, 1988). However,
if some receptors remained in the low-affinity state, they would not be resolved in the
filtration assay due to the fast dissociation rate.
To further purify the material, the purified receptors can be subjected to size-
based separation methods. We have used sucrose density gradient centrifugation and
gel filtration to separate aggregates and monomers from the desired single particles
of assembled receptors (IV, and unpublished work). GluRD and GluRB receptor
preparations treated this way have been found to be relatively homogeneous in an
electron microscopical analysis (Dr. Dean Madden, Max Planck Institute for Medical
Research, Heidelberg). In gel filtration the purified GluRD particles had an apparent
molecular weight of 550 kDa as a detergent complex (IV). As the amount of detergent
bound to the receptor was unknown, the size is consistent with a tetra- or pentameric
assembly.
Due to the inherent difficulty in crystallising membrane proteins, only about
a dozen structures are available for them. Following the first determination of a crystal
structure of an integral membrane protein, the photosynthetic reaction centre of
Rhodopseudomonas viridis (Michel, 1982), several X-ray and a few electron
crystallographic structures of membrane proteins have been obtained at higher than
3.5Å resolution (reviewed by Sakai and Tsukihara, 1998). Generally, those membrane
proteins for which the structure has been solved are abundant in nature or they can be
produced on a large scale in bacteria. Remarkably, the structure of a bacterial K+-
channel, KcsA, which is similar to the pore domain of a eucaryotic potassium channel,
has been solved (Doyle et al., 1998). No crystal structures are yet available for any
neurotransmitter receptors, but a reasonably high resolution structure (4.6Å) has been
obtained by electron microscopy for the acetylcholine receptor (Miyazawa, 1999).
4.2. THE LIGAND BINDING SITE AS AN INDEPENDENT FRAGMENT
In 1994, when the present study was initiated, the membrane topology of
GluR subunits was controversial. In AMPAR subunits there are two discontinuous
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segments that resemble the bacterial periplasmic polar amino acid –binding proteins
(Nakanishi et al., 1990). These segments, S1 and S2, are located before the first putative
transmembrane segment and between the third and fourth segment, respectively.
Phosphorylation was reported in the S2 segment at residue Ser684 in GluR6 and
Ser627 in GluRA suggesting that S1 and S2 were on opposite sides of the membrane
(Wang et al., 1993; Raymond et al., 1993; Yakel et al., 1995). On the other hand,
glycosylation was reported at GluR6 residue Asn720 suggesting that there could be a
fifth transmembrane domain in the middle of S2 segment (Roche et al., 1994; Taverna
et al., 1994). However, several studies indicated that the second transmembrane domain
M2 has a loop structure (Wo and Oswald, 1994; Hollmann et al., 1994; Bennet and
Dingledine, 1995); this places the S1 and S2 segments both extracellularly, provided
that M3 is a true transmembrane segment. A study of chimaeric receptors identified
the essential role of the S1 and S2 regions in GluRC and GluR6 in the determination
of the ligand pharmacology (Stern-Bach et al., 1994). To solve the controversy in
topology and to provide definitive proof for the role of S1 and S2 segments in ligand
binding, a set of soluble constructs of an AMPA receptor GluRD was designed.
Constructs of different segments of the suspected extracellular parts were
made, including the N-terminal domain XS1, the PBP homology domains S1 and S2
separately and as a fusion protein joined together with a hydrophilic linker, S1S2. The
S1S2 fusion protein was secreted into the insect cell culture medium, bound [3H]AMPA
with a high affinity (Kd=50 nM) and reproduced the binding characteristics typical for
an AMPA receptor. This demonstrates that the structures needed for high affinity
ligand-binding lie within the S1 and S2 segments, and since separate S1 and S2 segments
were inactive, they are both necessary for this property. This result also indicates that
in order to form a ligand binding domain, the S1 and S2 segments must lie on the
same, extracellular side of the membrane. The separately expressed S2 segment was
secreted poorly for unknown reasons. We do not believe that the membrane-associated
segments within S2 could be the cause for the poor secretion since the whole S1S2
construct is secreted efficiently.
Moreover, we also found that the linker peptide between the S1 and S2
segments is not critical for high-affinity ligand binding, as a version with a minimal
linker of just two amino acids was found to behave similarly to the original S1S2
construct (Keinänen et al., 1997).
To study the structural determinants of ligand binding in another GluR subtype,
the minimal ligand-binding domains of a kainate receptor GluR6 were constructed
(S1[M1-M3]S2, S1S2-M4 and S1S2) and expressed in High Five insect cells. The
intact GluR6 exhibits high-affinity [3H]kainate binding, but somewhat surprisingly, 6/
S1S2 did not exhibit any specific [3H]kainate binding. However, the two membrane
anchored constructs, S1[M1-M3]S2 and S1S2-M4, exhibited high affinity kainate binding
that was displaced with L-glutamate. These observations suggested that a solid support
could be important for the detection of ligand binding activity, accordingly Sepharose
beads were used as a substitute for the membrane anchor. With a modified binding
assay using Sepharose-bound S1S2-samples it was possible to detect specific binding
of [3H]kainate. The binding did not saturate, however, making it difficult to determine
the accurate affinity of kainate-binding. The binding of all agonists (kainate, L-glutamate
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and domoate) was of relatively low affinity, but the affinity for the antagonist CNQX
was not greatly altered compared to membrane-bound GluR6. This shows that agonists
and antagonists require different conformations for their binding and the agonist affinity
was affected more severely in the GluR6/S1S2 fusion protein.
A similar minimal ligand-binding domain was later constructed for the glycine-
binding domain of the NR1 subunit and expressed in insect cells. However, it showed
lower affinities for all of the measured agonists as compared to the membrane-bound
NR1 receptors (Ivanovic et al., 1998). In contrast, a construct comprising the entire
extracellular domain of NR1, showed ligand-binding properties comparable to the
intact homomeric NR1 receptors (Miyazaki et al., 1999).
4.3. DETERMINANTS FOR LIGAND SELECTIVITY
GluR6 and GluRD belong to different GluR families and do not co-assemble
into native glutamate receptors (Partin et al., 1993; Puchalski et al., 1994). They share
~40% overall amino acid identity, but show different ligand selectivities. AMPA receptors
show a rank order of agonist potency: quisqualate> AMPA> domoate> L-glutamate>
kainate. Conversely, the rank order of agonist potencies at the kainate receptors is
domoate> kainate> quisqualate> L-glutamate.
Chimaeric ligand binding domains of these two subunits were constructed in
order to study the relative roles of S1 and S2 in ligand recognition and to locate the
determinants responsible for different agonist selectivities. For [3H]AMPA-binding
the origin of the S1 segment was not critical, but the GluRD N-terminal third of the
S2 segment (residues 649–709 in GluRD) was needed, suggesting that some critical
residues for recognition of agonist AMPA lie within this segment. [3H]Kainate-binding,
on the other hand, was dependent on the 6/S1 segment suggesting that the segment
harbors relevant residues for the specificity towards kainate that are not present in D/
S1. These results are consistent with the findings on chimaeras made between
membrane-bound GluRC and GluR6 subunits (Stern-Bach et al., 1994).
Point mutations have also been studied in order to find out the determinants
for ligand recognition (reviewed in Dingledine et al., 1999). In the N-terminal region
of S2, which in this study was found to be critical for ligand binding, two residues
(L646 and S650) in AMPA receptor GluRA were found to decrease desensitisation
(Mano et al., 1996). The crystal structure of GluRB S1S2 revealed the presence of
three residues (G653, S654 T655) in the N-terminal part of S2 that are critical for
interactions with ligand (Armstrong et al., 1998).
4.4. BIOCHEMICAL ANALYSIS OF OTHER EXTRACELLULAR DOMAINS
To analyse the properties of extracellular domains and to locate determinants
involved in the oligomerisation of iGluRs, we studied soluble fragments of GluRD
extracellular segments. Two previously uncharacterised protein domains were
constructed: the whole ectodomain (XS1S2) and the first ~400 residues (X).  For
comparison, S1S2 and the N-terminal stretch before the first transmembrane domain
(XS1) were included in the studies. In a suspension culture of High Five insect cells,
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each construct was secreted into the culture medium. Purification of these receptor
fragments was carried out in a one-step metal chelation chromatography with the use
of a His-tag engineered at the C-termini of the constructs. The yields were between
0.1-2 mg from one liter of culture.
The sequence similarity with the bacterial leucine/isoleucine/-valine-binding
protein (LIVBP) suggested a role for the X domain in ligand binding. To address this
issue, ligand-binding properties of XS1S2 and S1S2 were compared by filtration assay
and fluorescence-based titration and stopped-flow kinetic measurements. These showed
that the affinities for the agonists AMPA, glutamate and kainate, as well as for the
antagonist DNQX, are comparable in XS1S2 and S1S2. Thus, the presence of X does
not impart any change in the ligand-binding event. This is consistent with an earlier
study showing that swapping of the X segments did not alter the ligand binding properties
of the GluRC-GluR6 chimaeras compared to parental proteins (Stern-Bach et al., 1994).
How do we know that the purified X domain is folded close to its native structure
as there is no functional assay available? First, it is secreted into the culture medium,
thus suggesting that it is processed correctly by the cells secretion machinery. Second,
XS1S2 exhibits high-affinity ligand binding suggesting that the overall structure must
be native-like. Furthermore, a monoclonal antibody, Fab21, recognised both intact
solubilised GluRD and GluRD/X in a conformation-specific manner (Jespersen et al.,
2000). Taken together, these results strongly suggest that the X fragment is correctly
folded.
The hydrodynamic size and oligomerisation state of the soluble fragments
were analysed by calculation of native molecular weights using the diffusion and
sedimentation coefficients obtained from gel filtration and sucrose density gradient
centrifugation. Molecular weights of 41 kDa, 86 kDa and 169 kDa were obtained for
the S1S2, X and XS1S2 fragments, respectively. These values are consistent with the
X and XS1S2 domains being dimers and the S1S2 domain being a monomer.
The molecules were analysed further by covalent cross-linking of the purified
fragments by glutaraldehyde, a relatively efficient and non-specific cross-linker. The
ectodomain (XS1S2) was cross-linked efficiently, but only a faint 100 kDa-band was
seen with the glutaraldehyde-treated X fragment and no formation of higher molecular
weight complexes was observed under the same conditions with S1S2. XS1S2 consisted
of mainly a 160-200 kDa species as detected by density gradient centrifugation of
cross-linked XS1S2.
In conclusion, the ligand-binding domain S1S2 behaves as a monomer in
solution. This is consistent with recent low-angle X-ray scattering studies, which
indicate a size of 45 kDa for GluRD/S1S2 (Abele et al., 1999). In addition, bacterially
produced GluRB/S1S2 has been shown to be a monomer by gel filtration (Chen and
Gouaux, 1997). The X fragment seems to dimerise spontaneously upon production in
insect cells as does the whole ectodomain XS1S2. Oligomerisation of the ligand-
binding site does not seem to affect the ligand binding characteristics as XS1S2 is
dimeric and S1S2 is monomeric in solution and yet they show identical binding
properties.
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At this point, the relevance of the present findings upon the oligomerisation of
the intact receptor is not entirely clear. It is interesting, however, that since the intact
membrane bound GluRD is at least a tetramer, these ectodomain-dimers may represent
an intermediate in assembly. Similar events have been suggested to take place with the
nicotinic acetylcholine receptors. They are proposed to form first dimers and trimers,
which then assemble into pentamers (Saedi et al., 1991).
The ectodomain of AMPA receptors interacts with other synaptic proteins as
was demonstrated with the Narp protein, which induces clustering of AMPA receptors
(O’Brien et al., 1999). Expression of the ectodomain and the separate domains thereof
as soluble proteins enables the studies of the interactions in more detail, especially
studies on the interacting parts of the receptor. Furthermore, characterisation of binding
sites for potential modulatory agents should be now feasible.
4.5. CONCLUDING REMARKS
Glutamate receptors of NMDA, AMPA and kainate subtypes mediate
excitatory neurotransmission and are involved in memory formation, learning and in
disorders of the nervous system.  Despite extensive molecular characterisation, many
fundamental questions relating to their structure and function have remained
unanswered and thus warrant further biochemical analysis.
In this study, two homomeric glutamate receptors, an AMPA-selective GluRD
and a kainate-selective GluR6, were expressed in Sf21 insect cell cultures. Membranes
of cells expressing the homomeric receptors bound their respective ligands with high
affinity and specificity and maintained the pharmacology typical for receptors described
in mammalian expression systems. Purification of an AMPA type glutamate receptor
was achieved by using a protocol based on affinity tags. A recombinant GluRD subunit
was engineered to carry a FLAG tag on its amino-terminus and a His tag on the
carboxy-terminus. Two affinity chromatography steps were employed, after which
the receptor was the only component in the preparation based on visual inspection of
the silver-stained protein gels. Yields were 50-100 µg from a two-liter batch of insect
cell suspension culture, and this protocol should be easily extendable to other receptor
subunits. Production of sufficient amounts of homomeric glutamate receptors for
biochemical and structural studies has thus been established.
Dissection of the receptor subunit into functional domains lead to the
identification of the S1 and S2 segments as the ligand binding sites of GluRD and
GluR6. The expression of ligand binding domains as soluble fragments opens a whole
new approach to study the molecular basis for ligand binding. A segment conferring
AMPA selectivity was located to the S2 segment by use of chimaeric S1S2 proteins.
The ectodomain of GluRD, which comprises all of the extracellularly exposed parts
of the receptor, was also expressed as a soluble secreted protein. The ectodomain and
its N-terminal part, the X domain, were dimers in contrast to the monomeric S1S2.
The present work also demonstrates that intact glutamate receptors and their
soluble extracellular domains can be produced and purified in milligram amounts,
thus facilitating their structural analysis. Recently, a crystal structure of the S1S2
fusion protein of GluRB with a bound non-desensitising agonist kainate has been
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reported (Armstrong et al., 1998). Further structures of the entire extracellular domain
and of the N-terminal segment are now also within experimental reach, and should aid
in the understanding of the ligand binding event, the basis for allosteric regulation and
the mechanism of the ligand induced opening of the channel.
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